UA108856C2 - Пунікалін (punicalin) та пунікалагін (punicalagin) для захисту здоров'я головного мозку при нейродегенеративних розладах - Google Patents

Info

Publication number

UA108856C2

UA108856C2 UAA201202090A UAA201202090A UA108856C2 UA 108856 C2 UA108856 C2 UA 108856C2 UA A201202090 A UAA201202090 A UA A201202090A UA A201202090 A UAA201202090 A UA A201202090A UA 108856 C2 UA108856 C2 UA 108856C2

Authority

UA

Ukraine

Prior art keywords

disease

condition

memory

present

disorder

Prior art date

2009-07-24

Links

• Espacenet
• Global Dossier
• Discuss

• 208000015122 neurodegenerative disease Diseases 0.000 title claims abstract description 23
• 229920000241 Punicalagin Polymers 0.000 title claims abstract description 20
• ZJVUMAFASBFUBG-OGJBWQGYSA-N punicalagin Chemical compound C([C@H]1O[C@@H]([C@@H]2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)O[C@H]2[C@@H]1OC(=O)C1=CC(O)=C(O)C(O)=C11)O)OC(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(OC3=O)C4=C2C(=O)OC2=C4C3=C1C(O)=C2O ZJVUMAFASBFUBG-OGJBWQGYSA-N 0.000 title claims abstract description 20
• LMIBIMUSUFYFJN-RSVYENFWSA-N punicalagin Natural products O[C@@H]1O[C@@H]2COC(=O)c3cc(O)c(O)c(O)c3c4c(O)cc5OC(=O)c6c(c(O)c(O)c7OC(=O)c4c5c67)c8c(O)c(O)c(O)cc8C(=O)O[C@H]2[C@@H]9OC(=O)c%10cc(O)c(O)c(O)c%10c%11c(O)c(O)c(O)cc%11C(=O)O[C@@H]19 LMIBIMUSUFYFJN-RSVYENFWSA-N 0.000 title claims abstract description 20
• ZRKSVMFLACVUIU-UHFFFAOYSA-N punicalagin isomer Natural products OC1=C(O)C(=C2C3=4)OC(=O)C=4C4=C(O)C(O)=C3OC(=O)C2=C1C1=C(O)C(O)=C(O)C=C1C(=O)OC1C2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(O)OC1COC(=O)C1=CC4=C(O)C(O)=C1O ZRKSVMFLACVUIU-UHFFFAOYSA-N 0.000 title claims abstract description 20
• SSIRGMIVWUBXFB-UHFFFAOYSA-N punicalin Natural products OC1OC2COC(=O)c3cc(O)c(O)c(O)c3c4c(O)c(O)c5OC(=O)c6c(c(O)c(O)c7OC(=O)c4c5c67)c8cc(C(=O)OC2C(O)C1O)c(O)c(O)c8O SSIRGMIVWUBXFB-UHFFFAOYSA-N 0.000 title claims abstract description 15
• 229920000864 Punicalin Polymers 0.000 title claims abstract description 12
• IQHIEHIKNWLKFB-ITTSEVFZSA-N pumcalin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1OC(=O)C1=CC(O)=C(O)C(O)=C11)O)O)OC(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(OC3=O)C4=C2C(=O)OC2=C4C3=C1C(O)=C2O IQHIEHIKNWLKFB-ITTSEVFZSA-N 0.000 title claims abstract description 12
• 230000036541 health Effects 0.000 title description 6
• 230000036995 brain health Effects 0.000 title description 4
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 102
• 201000010099 disease Diseases 0.000 claims abstract description 73
• 238000011282 treatment Methods 0.000 claims abstract description 57
• 206010002022 amyloidosis Diseases 0.000 claims abstract description 33
• 208000010877 cognitive disease Diseases 0.000 claims abstract description 30
• 208000035475 disorder Diseases 0.000 claims abstract description 28
• 208000024827 Alzheimer disease Diseases 0.000 claims abstract description 25
• 208000026139 Memory disease Diseases 0.000 claims abstract description 23
• 230000002265 prevention Effects 0.000 claims abstract description 13
• 230000035484 reaction time Effects 0.000 claims abstract description 8
• 201000003723 learning disability Diseases 0.000 claims abstract description 5
• 208000020358 Learning disease Diseases 0.000 claims abstract description 4
• 150000001875 compounds Chemical class 0.000 claims description 258
• 239000000203 mixture Substances 0.000 claims description 182
• 239000000284 extract Substances 0.000 claims description 173
• 238000000034 method Methods 0.000 claims description 141
• -1 hydrate Substances 0.000 claims description 90
• 150000003839 salts Chemical class 0.000 claims description 65
• 230000015654 memory Effects 0.000 claims description 64
• 235000013305 food Nutrition 0.000 claims description 52
• 239000000651 prodrug Substances 0.000 claims description 52
• 229940002612 prodrug Drugs 0.000 claims description 52
• 239000000126 substance Substances 0.000 claims description 46
• 239000012453 solvate Substances 0.000 claims description 41
• 239000002207 metabolite Substances 0.000 claims description 40
• 241001465754 Metazoa Species 0.000 claims description 38
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
• 238000004128 high performance liquid chromatography Methods 0.000 claims description 32
• 239000000047 product Substances 0.000 claims description 30
• 235000015872 dietary supplement Nutrition 0.000 claims description 29
• 239000003814 drug Substances 0.000 claims description 23
• 229910052739 hydrogen Inorganic materials 0.000 claims description 20
• 229940079593 drug Drugs 0.000 claims description 19
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 16
• 239000002417 nutraceutical Substances 0.000 claims description 15
• 235000021436 nutraceutical agent Nutrition 0.000 claims description 15
• 208000028698 Cognitive impairment Diseases 0.000 claims description 14
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 14
• 230000001976 improved effect Effects 0.000 claims description 14
• 208000018737 Parkinson disease Diseases 0.000 claims description 13
• 210000004556 brain Anatomy 0.000 claims description 13
• 230000003930 cognitive ability Effects 0.000 claims description 13
• 235000013373 food additive Nutrition 0.000 claims description 13
• 239000002778 food additive Substances 0.000 claims description 13
• 235000013376 functional food Nutrition 0.000 claims description 13
• 206010027175 memory impairment Diseases 0.000 claims description 13
• 230000008569 process Effects 0.000 claims description 13
• 241000699670 Mus sp. Species 0.000 claims description 11
• 229940126601 medicinal product Drugs 0.000 claims description 11
• 208000023105 Huntington disease Diseases 0.000 claims description 10
• 230000007787 long-term memory Effects 0.000 claims description 10
• 230000005056 memory consolidation Effects 0.000 claims description 10
• 229910052757 nitrogen Inorganic materials 0.000 claims description 10
• 239000008194 pharmaceutical composition Substances 0.000 claims description 10
• 208000027061 mild cognitive impairment Diseases 0.000 claims description 9
• 238000005406 washing Methods 0.000 claims description 9
• 241000699666 Mus <mouse, genus> Species 0.000 claims description 8
• 201000010374 Down Syndrome Diseases 0.000 claims description 7
• 235000010469 Glycine max Nutrition 0.000 claims description 7
• 230000006403 short-term memory Effects 0.000 claims description 6
• 230000009471 action Effects 0.000 claims description 5
• 238000004519 manufacturing process Methods 0.000 claims description 5
• 235000013311 vegetables Nutrition 0.000 claims description 4
• 235000017848 Rubus fruticosus Nutrition 0.000 claims description 3
• 238000007792 addition Methods 0.000 claims description 3
• 229910052796 boron Inorganic materials 0.000 claims description 2
• 230000012010 growth Effects 0.000 claims description 2
• 244000068988 Glycine max Species 0.000 claims 2
• 101500020117 Aedes aegypti Sialokinin Proteins 0.000 claims 1
• 101100049050 Arabidopsis thaliana PVA41 gene Proteins 0.000 claims 1
• 240000005220 Bischofia javanica Species 0.000 claims 1
• 235000010893 Bischofia javanica Nutrition 0.000 claims 1
• 241000566113 Branta sandvicensis Species 0.000 claims 1
• 101100123850 Caenorhabditis elegans her-1 gene Proteins 0.000 claims 1
• 206010010071 Coma Diseases 0.000 claims 1
• 241001327708 Coriaria sarmentosa Species 0.000 claims 1
• ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims 1
• 241001397173 Kali <angiosperm> Species 0.000 claims 1
• 241000824268 Kuma Species 0.000 claims 1
• 101100498160 Mus musculus Dach1 gene Proteins 0.000 claims 1
• 241001318330 Nenia Species 0.000 claims 1
• 101800001775 Nuclear inclusion protein A Proteins 0.000 claims 1
• 241000567149 Ochna serrulata Species 0.000 claims 1
• 241000997494 Oneirodidae Species 0.000 claims 1
• 240000000220 Panda oleosa Species 0.000 claims 1
• 235000016496 Panda oleosa Nutrition 0.000 claims 1
• 240000007643 Phytolacca americana Species 0.000 claims 1
• 244000000231 Sesamum indicum Species 0.000 claims 1
• 235000003434 Sesamum indicum Nutrition 0.000 claims 1
• ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims 1
• 241000838698 Togo Species 0.000 claims 1
• CCAZWUJBLXKBAY-ULZPOIKGSA-N Tutin Chemical compound C([C@]12[C@@H]3O[C@@H]3[C@@]3(O)[C@H]4C(=O)O[C@@H]([C@H]([C@]32C)O)[C@H]4C(=C)C)O1 CCAZWUJBLXKBAY-ULZPOIKGSA-N 0.000 claims 1
• 210000005056 cell body Anatomy 0.000 claims 1
• 210000000720 eyelash Anatomy 0.000 claims 1
• 238000005242 forging Methods 0.000 claims 1
• 244000145841 kine Species 0.000 claims 1
• 238000009331 sowing Methods 0.000 claims 1
• 208000034189 Sclerosis Diseases 0.000 abstract 1
• 208000029078 coronary artery disease Diseases 0.000 abstract 1
• 238000012360 testing method Methods 0.000 description 68
• 235000002639 sodium chloride Nutrition 0.000 description 65
• 230000002776 aggregation Effects 0.000 description 41
• 238000004220 aggregation Methods 0.000 description 41
• 239000003795 chemical substances by application Substances 0.000 description 37
• 241000700159 Rattus Species 0.000 description 33
• 235000018102 proteins Nutrition 0.000 description 33
• 102000004169 proteins and genes Human genes 0.000 description 33
• 108090000623 proteins and genes Proteins 0.000 description 33
• 241000196324 Embryophyta Species 0.000 description 29
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 29
• 125000000217 alkyl group Chemical group 0.000 description 28
• 230000000694 effects Effects 0.000 description 27
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
• 239000000969 carrier Substances 0.000 description 24
• 235000000346 sugar Nutrition 0.000 description 22
• 210000004027 cell Anatomy 0.000 description 21
• 239000000463 material Substances 0.000 description 21
• 239000000843 powder Substances 0.000 description 21
• 108090000765 processed proteins & peptides Proteins 0.000 description 21
• 229920005989 resin Polymers 0.000 description 21
• 239000011347 resin Substances 0.000 description 21
• 241000219991 Lythraceae Species 0.000 description 19
• 235000014360 Punica granatum Nutrition 0.000 description 19
• 235000013824 polyphenols Nutrition 0.000 description 19
• 239000002904 solvent Substances 0.000 description 19
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 18
• 238000009472 formulation Methods 0.000 description 18
• LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 18
• 239000001257 hydrogen Substances 0.000 description 18
• 150000008442 polyphenolic compounds Chemical class 0.000 description 18
• 125000001424 substituent group Chemical group 0.000 description 17
• 238000011287 therapeutic dose Methods 0.000 description 17
• 150000001720 carbohydrates Chemical class 0.000 description 16
• 230000015572 biosynthetic process Effects 0.000 description 14
• 235000014633 carbohydrates Nutrition 0.000 description 14
• 150000004677 hydrates Chemical class 0.000 description 14
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 14
• 230000001965 increasing effect Effects 0.000 description 14
• 239000003826 tablet Substances 0.000 description 14
• 125000003710 aryl alkyl group Chemical group 0.000 description 13
• 125000004432 carbon atom Chemical group C* 0.000 description 13
• 235000011187 glycerol Nutrition 0.000 description 13
• 229960005150 glycerol Drugs 0.000 description 13
• 125000003118 aryl group Chemical group 0.000 description 12
• 239000002775 capsule Substances 0.000 description 12
• 235000019441 ethanol Nutrition 0.000 description 12
• NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 12
• 210000001519 tissue Anatomy 0.000 description 12
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 11
• 230000006378 damage Effects 0.000 description 11
• 239000007788 liquid Substances 0.000 description 11
• 239000000243 solution Substances 0.000 description 11
• 238000012549 training Methods 0.000 description 11
• 208000037259 Amyloid Plaque Diseases 0.000 description 10
• 241000124008 Mammalia Species 0.000 description 10
• 239000002253 acid Substances 0.000 description 10
• 230000009286 beneficial effect Effects 0.000 description 10
• 235000013361 beverage Nutrition 0.000 description 10
• 125000001188 haloalkyl group Chemical group 0.000 description 10
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 10
• 238000001179 sorption measurement Methods 0.000 description 10
• 229940088594 vitamin Drugs 0.000 description 10
• 229930003231 vitamin Natural products 0.000 description 10
• 235000013343 vitamin Nutrition 0.000 description 10
• 239000011782 vitamin Substances 0.000 description 10
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 9
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
• 239000003963 antioxidant agent Substances 0.000 description 9
• 235000006708 antioxidants Nutrition 0.000 description 9
• 230000001149 cognitive effect Effects 0.000 description 9
• 235000005911 diet Nutrition 0.000 description 9
• 239000000945 filler Substances 0.000 description 9
• 238000005194 fractionation Methods 0.000 description 9
• 235000011389 fruit/vegetable juice Nutrition 0.000 description 9
• 229940074391 gallic acid Drugs 0.000 description 9
• 235000004515 gallic acid Nutrition 0.000 description 9
• 150000002431 hydrogen Chemical class 0.000 description 9
• 239000000787 lecithin Substances 0.000 description 9
• 235000010445 lecithin Nutrition 0.000 description 9
• 229940067606 lecithin Drugs 0.000 description 9
• 229920001223 polyethylene glycol Polymers 0.000 description 9
• 229920000642 polymer Polymers 0.000 description 9
• 238000002360 preparation method Methods 0.000 description 9
• 230000001988 toxicity Effects 0.000 description 9
• 231100000419 toxicity Toxicity 0.000 description 9
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
• 239000003463 adsorbent Substances 0.000 description 8
• 125000003342 alkenyl group Chemical group 0.000 description 8
• 125000003545 alkoxy group Chemical group 0.000 description 8
• 125000000304 alkynyl group Chemical group 0.000 description 8
• 230000006399 behavior Effects 0.000 description 8
• 238000005119 centrifugation Methods 0.000 description 8
• 229920001429 chelating resin Polymers 0.000 description 8
• 230000037213 diet Effects 0.000 description 8
• 235000014113 dietary fatty acids Nutrition 0.000 description 8
• 238000010828 elution Methods 0.000 description 8
• 239000003995 emulsifying agent Substances 0.000 description 8
• 238000005516 engineering process Methods 0.000 description 8
• 238000000605 extraction Methods 0.000 description 8
• 229930195729 fatty acid Natural products 0.000 description 8
• 239000000194 fatty acid Substances 0.000 description 8
• 150000004665 fatty acids Chemical class 0.000 description 8
• 125000003709 fluoroalkyl group Chemical group 0.000 description 8
• 239000008103 glucose Substances 0.000 description 8
• 125000001072 heteroaryl group Chemical group 0.000 description 8
• 229910052500 inorganic mineral Inorganic materials 0.000 description 8
• 230000003993 interaction Effects 0.000 description 8
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
• 235000010755 mineral Nutrition 0.000 description 8
• 239000011707 mineral Substances 0.000 description 8
• 230000004770 neurodegeneration Effects 0.000 description 8
• 210000002569 neuron Anatomy 0.000 description 8
• 239000003921 oil Substances 0.000 description 8
• 125000004430 oxygen atom Chemical group O* 0.000 description 8
• GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 7
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
• 239000000443 aerosol Substances 0.000 description 7
• 229940024606 amino acid Drugs 0.000 description 7
• 150000001413 amino acids Chemical group 0.000 description 7
• 238000003556 assay Methods 0.000 description 7
• 239000000872 buffer Substances 0.000 description 7
• 239000002552 dosage form Substances 0.000 description 7
• 235000019198 oils Nutrition 0.000 description 7
• 102000004196 processed proteins & peptides Human genes 0.000 description 7
• 239000007787 solid Substances 0.000 description 7
• 230000001225 therapeutic effect Effects 0.000 description 7
• 238000000108 ultra-filtration Methods 0.000 description 7
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
• SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 6
• SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 6
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 6
• IYMHVUYNBVWXKH-ZITZVVOASA-N Pedunculagin Chemical compound C([C@H]1OC2O)OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)O[C@H]1[C@H]1[C@H]2OC(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(O)C=C2C(=O)O1 IYMHVUYNBVWXKH-ZITZVVOASA-N 0.000 description 6
• 229920000158 Pedunculagin Polymers 0.000 description 6
• HVXQPVRDPFKKHP-UHFFFAOYSA-N Pedunculagin Natural products OC1C2COC(=O)c3cc(O)c(O)c(O)c3c4c(O)c(O)c(O)cc4C(=O)OC(O2)C5OC(=O)c6cc(O)c(O)c(O)c6c7c(O)c(O)c(O)cc7C(=O)OC15 HVXQPVRDPFKKHP-UHFFFAOYSA-N 0.000 description 6
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
• 229930006000 Sucrose Natural products 0.000 description 6
• 125000004448 alkyl carbonyl group Chemical group 0.000 description 6
• 125000005157 alkyl carboxy group Chemical group 0.000 description 6
• 238000004458 analytical method Methods 0.000 description 6
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 6
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 6
• MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 6
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
• OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 6
• 238000010411 cooking Methods 0.000 description 6
• RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 6
• 231100000673 dose–response relationship Toxicity 0.000 description 6
• 239000003937 drug carrier Substances 0.000 description 6
• 235000013399 edible fruits Nutrition 0.000 description 6
• OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
• 230000006870 function Effects 0.000 description 6
• 239000000499 gel Substances 0.000 description 6
• 229910052736 halogen Inorganic materials 0.000 description 6
• 150000002367 halogens Chemical group 0.000 description 6
• 125000000623 heterocyclic group Chemical group 0.000 description 6
• 230000002401 inhibitory effect Effects 0.000 description 6
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
• 230000000670 limiting effect Effects 0.000 description 6
• 235000016709 nutrition Nutrition 0.000 description 6
• 210000000056 organ Anatomy 0.000 description 6
• IYMHVUYNBVWXKH-UHFFFAOYSA-N pedunculagin I isomer Natural products OC1OC2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C2C1OC(=O)C1=CC(O)=C(O)C(O)=C1C1=C(O)C(O)=C(O)C=C1C(=O)O2 IYMHVUYNBVWXKH-UHFFFAOYSA-N 0.000 description 6
• 229940109529 pomegranate extract Drugs 0.000 description 6
• 239000003755 preservative agent Substances 0.000 description 6
• 239000005720 sucrose Substances 0.000 description 6
• 150000008163 sugars Chemical class 0.000 description 6
• 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 6
• 229910052717 sulfur Inorganic materials 0.000 description 6
• 239000000725 suspension Substances 0.000 description 6
• 235000013616 tea Nutrition 0.000 description 6
• XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc oxide Inorganic materials [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
• GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 6
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 5
• 229940126062 Compound A Drugs 0.000 description 5
• NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 5
• 238000012347 Morris Water Maze Methods 0.000 description 5
• LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 5
• 206010028980 Neoplasm Diseases 0.000 description 5
• 244000269722 Thea sinensis Species 0.000 description 5
• 230000003078 antioxidant effect Effects 0.000 description 5
• 239000002585 base Substances 0.000 description 5
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 5
• 210000000170 cell membrane Anatomy 0.000 description 5
• 229960001231 choline Drugs 0.000 description 5
• 239000000975 dye Substances 0.000 description 5
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
• 238000002474 experimental method Methods 0.000 description 5
• 239000012634 fragment Substances 0.000 description 5
• WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 5
• 239000007789 gas Substances 0.000 description 5
• 230000001771 impaired effect Effects 0.000 description 5
• 230000006872 improvement Effects 0.000 description 5
• 210000004185 liver Anatomy 0.000 description 5
• 238000001819 mass spectrum Methods 0.000 description 5
• 239000002245 particle Substances 0.000 description 5
• 239000000546 pharmaceutical excipient Substances 0.000 description 5
• 239000006187 pill Substances 0.000 description 5
• 238000003825 pressing Methods 0.000 description 5
• 230000002829 reductive effect Effects 0.000 description 5
• 238000011160 research Methods 0.000 description 5
• RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 5
• 238000001228 spectrum Methods 0.000 description 5
• 239000013589 supplement Substances 0.000 description 5
• 230000009885 systemic effect Effects 0.000 description 5
• 231100000331 toxic Toxicity 0.000 description 5
• 230000002588 toxic effect Effects 0.000 description 5
• 230000009466 transformation Effects 0.000 description 5
• 150000003722 vitamin derivatives Chemical class 0.000 description 5
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
• 108010010803 Gelatin Proteins 0.000 description 4
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
• DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
• 206010035226 Plasma cell myeloma Diseases 0.000 description 4
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
• AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
• 108010073771 Soybean Proteins Proteins 0.000 description 4
• 229920002472 Starch Polymers 0.000 description 4
• 108010046377 Whey Proteins Proteins 0.000 description 4
• 150000007513 acids Chemical class 0.000 description 4
• 239000000654 additive Substances 0.000 description 4
• 230000032683 aging Effects 0.000 description 4
• 125000003302 alkenyloxy group Chemical group 0.000 description 4
• 125000002947 alkylene group Chemical group 0.000 description 4
• 125000005133 alkynyloxy group Chemical group 0.000 description 4
• FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
• 125000004429 atom Chemical group 0.000 description 4
• 230000004071 biological effect Effects 0.000 description 4
• 125000004452 carbocyclyl group Chemical group 0.000 description 4
• 239000011203 carbon fibre reinforced carbon Substances 0.000 description 4
• 238000006243 chemical reaction Methods 0.000 description 4
• 239000000544 cholinesterase inhibitor Substances 0.000 description 4
• 238000000576 coating method Methods 0.000 description 4
• 230000001143 conditioned effect Effects 0.000 description 4
• 235000009508 confectionery Nutrition 0.000 description 4
• VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 4
• RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• 230000018109 developmental process Effects 0.000 description 4
• 206010012601 diabetes mellitus Diseases 0.000 description 4
• 238000003745 diagnosis Methods 0.000 description 4
• 239000000539 dimer Substances 0.000 description 4
• ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 description 4
• 235000020188 drinking water Nutrition 0.000 description 4
• 239000003651 drinking water Substances 0.000 description 4
• 238000001035 drying Methods 0.000 description 4
• 239000003925 fat Substances 0.000 description 4
• 235000019197 fats Nutrition 0.000 description 4
• 239000000835 fiber Substances 0.000 description 4
• ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 description 4
• 239000008273 gelatin Substances 0.000 description 4
• 229920000159 gelatin Polymers 0.000 description 4
• 235000019322 gelatine Nutrition 0.000 description 4
• 235000011852 gelatine desserts Nutrition 0.000 description 4
• 239000008187 granular material Substances 0.000 description 4
• 125000005842 heteroatom Chemical group 0.000 description 4
• 150000002430 hydrocarbons Chemical class 0.000 description 4
• 230000005764 inhibitory process Effects 0.000 description 4
• 239000007924 injection Substances 0.000 description 4
• 238000002347 injection Methods 0.000 description 4
• 210000003734 kidney Anatomy 0.000 description 4
• 239000008101 lactose Substances 0.000 description 4
• 239000000314 lubricant Substances 0.000 description 4
• 235000019359 magnesium stearate Nutrition 0.000 description 4
• 239000002609 medium Substances 0.000 description 4
• 230000003340 mental effect Effects 0.000 description 4
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
• 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 4
• 235000013336 milk Nutrition 0.000 description 4
• 239000008267 milk Substances 0.000 description 4
• 210000004080 milk Anatomy 0.000 description 4
• 238000002156 mixing Methods 0.000 description 4
• 231100000252 nontoxic Toxicity 0.000 description 4
• 230000003000 nontoxic effect Effects 0.000 description 4
• 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 4
• 235000015097 nutrients Nutrition 0.000 description 4
• 239000006072 paste Substances 0.000 description 4
• 125000005328 phosphinyl group Chemical group [PH2](=O)* 0.000 description 4
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
• 208000022256 primary systemic amyloidosis Diseases 0.000 description 4
• 230000009467 reduction Effects 0.000 description 4
• 230000011514 reflex Effects 0.000 description 4
• 239000000523 sample Substances 0.000 description 4
• 229920006395 saturated elastomer Polymers 0.000 description 4
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 4
• 235000012239 silicon dioxide Nutrition 0.000 description 4
• 235000011888 snacks Nutrition 0.000 description 4
• 229940001941 soy protein Drugs 0.000 description 4
• 239000007921 spray Substances 0.000 description 4
• 238000010186 staining Methods 0.000 description 4
• 235000019698 starch Nutrition 0.000 description 4
• 208000024891 symptom Diseases 0.000 description 4
• 229940124597 therapeutic agent Drugs 0.000 description 4
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
• 239000002076 α-tocopherol Substances 0.000 description 4
• NTBYIQWZAVDRHA-KCDKBNATSA-N (2s,3s,4r,5s)-2-amino-3,4,5-trihydroxyhexanal Chemical compound C[C@H](O)[C@@H](O)[C@@H](O)[C@H](N)C=O NTBYIQWZAVDRHA-KCDKBNATSA-N 0.000 description 3
• MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 3
• FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
• MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 3
• MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 3
• MSWZFWKMSRAUBD-CBPJZXOFSA-N 2-amino-2-deoxy-D-mannopyranose Chemical compound N[C@@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-CBPJZXOFSA-N 0.000 description 3
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
• 241000416162 Astragalus gummifer Species 0.000 description 3
• 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 3
• 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 3
• 208000005145 Cerebral amyloid angiopathy Diseases 0.000 description 3
• 229920002261 Corn starch Polymers 0.000 description 3
• 244000163122 Curcuma domestica Species 0.000 description 3
• YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 3
• WQZGKKKJIJFFOK-CBPJZXOFSA-N D-Gulose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-CBPJZXOFSA-N 0.000 description 3
• WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 description 3
• WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 3
• YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 3
• MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 3
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 3
• ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 3
• ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 3
• ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 3
• 206010012289 Dementia Diseases 0.000 description 3
• 206010056474 Erythrosis Diseases 0.000 description 3
• 208000034846 Familial Amyloid Neuropathies Diseases 0.000 description 3
• 201000011240 Frontotemporal dementia Diseases 0.000 description 3
• 229930091371 Fructose Natural products 0.000 description 3
• 239000005715 Fructose Substances 0.000 description 3
• RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
• PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 3
• 244000194101 Ginkgo biloba Species 0.000 description 3
• 235000008100 Ginkgo biloba Nutrition 0.000 description 3
• 206010019889 Hereditary neuropathic amyloidosis Diseases 0.000 description 3
• SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 3
• 102000004877 Insulin Human genes 0.000 description 3
• 108090001061 Insulin Proteins 0.000 description 3
• 102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 3
• 108010041872 Islet Amyloid Polypeptide Proteins 0.000 description 3
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
• LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 3
• SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 3
• SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 3
• PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
• 229920002774 Maltodextrin Polymers 0.000 description 3
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
• 241000699660 Mus musculus Species 0.000 description 3
• OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
• PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
• 240000007594 Oryza sativa Species 0.000 description 3
• 235000007164 Oryza sativa Nutrition 0.000 description 3
• 239000002202 Polyethylene glycol Substances 0.000 description 3
• 208000028017 Psychotic disease Diseases 0.000 description 3
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 3
• OVVGHDNPYGTYIT-VHBGUFLRSA-N Robinobiose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1 OVVGHDNPYGTYIT-VHBGUFLRSA-N 0.000 description 3
• 208000006011 Stroke Diseases 0.000 description 3
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
• 244000299461 Theobroma cacao Species 0.000 description 3
• 229920001615 Tragacanth Polymers 0.000 description 3
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 3
• 244000078534 Vaccinium myrtillus Species 0.000 description 3
• 229930003427 Vitamin E Natural products 0.000 description 3
• 102000007544 Whey Proteins Human genes 0.000 description 3
• 125000002015 acyclic group Chemical group 0.000 description 3
• 230000000996 additive effect Effects 0.000 description 3
• 239000000853 adhesive Substances 0.000 description 3
• 230000001070 adhesive effect Effects 0.000 description 3
• 125000005090 alkenylcarbonyl group Chemical group 0.000 description 3
• 125000004453 alkoxycarbonyl group Chemical group 0.000 description 3
• 125000005196 alkyl carbonyloxy group Chemical group 0.000 description 3
• 125000004390 alkyl sulfonyl group Chemical group 0.000 description 3
• 125000005087 alkynylcarbonyl group Chemical group 0.000 description 3
• 229940087168 alpha tocopherol Drugs 0.000 description 3
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 3
• 229910052782 aluminium Inorganic materials 0.000 description 3
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
• 150000001412 amines Chemical class 0.000 description 3
• 125000003277 amino group Chemical group 0.000 description 3
• 125000001091 aminosulfinyl group Chemical group [H]N([H])S(*)=O 0.000 description 3
• 238000010171 animal model Methods 0.000 description 3
• 230000002744 anti-aggregatory effect Effects 0.000 description 3
• 239000007864 aqueous solution Substances 0.000 description 3
• PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 3
• 125000002102 aryl alkyloxo group Chemical group 0.000 description 3
• 125000004104 aryloxy group Chemical group 0.000 description 3
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
• 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 3
• 235000012216 bentonite Nutrition 0.000 description 3
• SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 3
• 125000002619 bicyclic group Chemical group 0.000 description 3
• 239000011230 binding agent Substances 0.000 description 3
• 229960002685 biotin Drugs 0.000 description 3
• 235000020958 biotin Nutrition 0.000 description 3
• 239000011616 biotin Substances 0.000 description 3
• 229910000019 calcium carbonate Inorganic materials 0.000 description 3
• 235000010216 calcium carbonate Nutrition 0.000 description 3
• 239000001506 calcium phosphate Substances 0.000 description 3
• 201000011510 cancer Diseases 0.000 description 3
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
• 239000001768 carboxy methyl cellulose Substances 0.000 description 3
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
• 238000004113 cell culture Methods 0.000 description 3
• 230000030833 cell death Effects 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 239000011248 coating agent Substances 0.000 description 3
• 230000037411 cognitive enhancing Effects 0.000 description 3
• 238000002648 combination therapy Methods 0.000 description 3
• 239000008120 corn starch Substances 0.000 description 3
• 229940099112 cornstarch Drugs 0.000 description 3
• 239000002537 cosmetic Substances 0.000 description 3
• 239000006071 cream Substances 0.000 description 3
• 238000002425 crystallisation Methods 0.000 description 3
• 230000008025 crystallization Effects 0.000 description 3
• 235000003373 curcuma longa Nutrition 0.000 description 3
• 125000004093 cyano group Chemical group *C#N 0.000 description 3
• 230000007850 degeneration Effects 0.000 description 3
• 239000003085 diluting agent Substances 0.000 description 3
• ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 3
• 239000006185 dispersion Substances 0.000 description 3
• 235000013601 eggs Nutrition 0.000 description 3
• 239000000839 emulsion Substances 0.000 description 3
• 239000002702 enteric coating Substances 0.000 description 3
• 238000009505 enteric coating Methods 0.000 description 3
• UQPHVQVXLPRNCX-UHFFFAOYSA-N erythrulose Chemical compound OCC(O)C(=O)CO UQPHVQVXLPRNCX-UHFFFAOYSA-N 0.000 description 3
• 150000002148 esters Chemical class 0.000 description 3
• 238000011156 evaluation Methods 0.000 description 3
• 235000013312 flour Nutrition 0.000 description 3
• 239000011888 foil Substances 0.000 description 3
• 229960000304 folic acid Drugs 0.000 description 3
• 235000019152 folic acid Nutrition 0.000 description 3
• 239000011724 folic acid Substances 0.000 description 3
• 235000003599 food sweetener Nutrition 0.000 description 3
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 3
• 229930182830 galactose Natural products 0.000 description 3
• 239000007903 gelatin capsule Substances 0.000 description 3
• 229960002442 glucosamine Drugs 0.000 description 3
• MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 3
• 229940093915 gynecological organic acid Drugs 0.000 description 3
• 125000005280 halo alkyl sulfonyloxy group Chemical group 0.000 description 3
• 125000004692 haloalkylcarbonyl group Chemical group 0.000 description 3
• 210000002216 heart Anatomy 0.000 description 3
• 125000004475 heteroaralkyl group Chemical group 0.000 description 3
• 125000004446 heteroarylalkyl group Chemical group 0.000 description 3
• 125000005553 heteroaryloxy group Chemical group 0.000 description 3
• 229930195733 hydrocarbon Natural products 0.000 description 3
• 150000004679 hydroxides Chemical class 0.000 description 3
• 125000002951 idosyl group Chemical class C1([C@@H](O)[C@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 3
• 238000003364 immunohistochemistry Methods 0.000 description 3
• 238000011534 incubation Methods 0.000 description 3
• 229960000367 inositol Drugs 0.000 description 3
• CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 3
• 229940125396 insulin Drugs 0.000 description 3
• WBJZTOZJJYAKHQ-UHFFFAOYSA-K iron(3+) phosphate Chemical compound [Fe+3].[O-]P([O-])([O-])=O WBJZTOZJJYAKHQ-UHFFFAOYSA-K 0.000 description 3
• BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 3
• 150000002632 lipids Chemical class 0.000 description 3
• 230000006742 locomotor activity Effects 0.000 description 3
• 230000014759 maintenance of location Effects 0.000 description 3
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
• 235000012054 meals Nutrition 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• 230000006993 memory improvement Effects 0.000 description 3
• 125000002950 monocyclic group Chemical group 0.000 description 3
• 239000000178 monomer Substances 0.000 description 3
• 150000002772 monosaccharides Chemical class 0.000 description 3
• 238000010172 mouse model Methods 0.000 description 3
• 210000002682 neurofibrillary tangle Anatomy 0.000 description 3
• 230000007135 neurotoxicity Effects 0.000 description 3
• 230000035764 nutrition Effects 0.000 description 3
• 235000020660 omega-3 fatty acid Nutrition 0.000 description 3
• 229940012843 omega-3 fatty acid Drugs 0.000 description 3
• 150000007524 organic acids Chemical class 0.000 description 3
• 235000005985 organic acids Nutrition 0.000 description 3
• 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 3
• 230000036542 oxidative stress Effects 0.000 description 3
• 229910052760 oxygen Inorganic materials 0.000 description 3
• 239000001301 oxygen Substances 0.000 description 3
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
• LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 3
• 229920003023 plastic Polymers 0.000 description 3
• 239000004033 plastic Substances 0.000 description 3
• 238000006116 polymerization reaction Methods 0.000 description 3
• 229920001282 polysaccharide Polymers 0.000 description 3
• 239000005017 polysaccharide Substances 0.000 description 3
• 150000004804 polysaccharides Chemical class 0.000 description 3
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
• 230000000750 progressive effect Effects 0.000 description 3
• 239000003380 propellant Substances 0.000 description 3
• 150000003254 radicals Chemical class 0.000 description 3
• BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 3
• 235000009566 rice Nutrition 0.000 description 3
• OVVGHDNPYGTYIT-BNXXONSGSA-N rutinose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 OVVGHDNPYGTYIT-BNXXONSGSA-N 0.000 description 3
• 235000014438 salad dressings Nutrition 0.000 description 3
• MEZLKOACVSPNER-GFCCVEGCSA-N selegiline Chemical compound C#CCN(C)[C@H](C)CC1=CC=CC=C1 MEZLKOACVSPNER-GFCCVEGCSA-N 0.000 description 3
• 229960003946 selegiline Drugs 0.000 description 3
• SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 3
• 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 3
• 239000011780 sodium chloride Substances 0.000 description 3
• 235000021055 solid food Nutrition 0.000 description 3
• 235000011496 sports drink Nutrition 0.000 description 3
• 239000003381 stabilizer Substances 0.000 description 3
• 229940032147 starch Drugs 0.000 description 3
• 239000008107 starch Substances 0.000 description 3
• 239000011593 sulfur Substances 0.000 description 3
• 125000004434 sulfur atom Chemical group 0.000 description 3
• 239000000829 suppository Substances 0.000 description 3
• 239000003765 sweetening agent Substances 0.000 description 3
• 239000006188 syrup Substances 0.000 description 3
• 235000020357 syrup Nutrition 0.000 description 3
• 239000000454 talc Substances 0.000 description 3
• 235000012222 talc Nutrition 0.000 description 3
• 229910052623 talc Inorganic materials 0.000 description 3
• 235000002906 tartaric acid Nutrition 0.000 description 3
• 239000011975 tartaric acid Substances 0.000 description 3
• 229960000984 tocofersolan Drugs 0.000 description 3
• 230000000699 topical effect Effects 0.000 description 3
• 235000010487 tragacanth Nutrition 0.000 description 3
• 239000000196 tragacanth Substances 0.000 description 3
• 229940116362 tragacanth Drugs 0.000 description 3
• 238000011830 transgenic mouse model Methods 0.000 description 3
• 201000007905 transthyretin amyloidosis Diseases 0.000 description 3
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
• 235000019731 tricalcium phosphate Nutrition 0.000 description 3
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
• 239000003981 vehicle Substances 0.000 description 3
• RXPRRQLKFXBCSJ-GIVPXCGWSA-N vincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@](O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-GIVPXCGWSA-N 0.000 description 3
• 235000019165 vitamin E Nutrition 0.000 description 3
• 239000011709 vitamin E Substances 0.000 description 3
• 229940046009 vitamin E Drugs 0.000 description 3
• 230000001755 vocal effect Effects 0.000 description 3
• 239000001993 wax Substances 0.000 description 3
• 239000000080 wetting agent Substances 0.000 description 3
• 235000021119 whey protein Nutrition 0.000 description 3
• 235000004835 α-tocopherol Nutrition 0.000 description 3
• WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 3
• GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 3
• PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
• DFUSDJMZWQVQSF-XLGIIRLISA-N (2r)-2-methyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 DFUSDJMZWQVQSF-XLGIIRLISA-N 0.000 description 2
• NTBYIQWZAVDRHA-JGWLITMVSA-N (2r,3r,4r,5r)-2-amino-3,4,5-trihydroxyhexanal Chemical compound C[C@@H](O)[C@@H](O)[C@H](O)[C@@H](N)C=O NTBYIQWZAVDRHA-JGWLITMVSA-N 0.000 description 2
• JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
• CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 2
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
• VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
• CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 2
• GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 2
• AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 2
• PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 2
• 208000023697 ABri amyloidosis Diseases 0.000 description 2
• 208000018282 ACys amyloidosis Diseases 0.000 description 2
• 208000017227 ADan amyloidosis Diseases 0.000 description 2
• 229940100578 Acetylcholinesterase inhibitor Drugs 0.000 description 2
• 229920001817 Agar Polymers 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
• 102000001049 Amyloid Human genes 0.000 description 2
• 108010094108 Amyloid Proteins 0.000 description 2
• LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
• 241000167854 Bourreria succulenta Species 0.000 description 2
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
• 208000024172 Cardiovascular disease Diseases 0.000 description 2
• 229910021555 Chromium Chloride Inorganic materials 0.000 description 2
• ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
• 240000007154 Coffea arabica Species 0.000 description 2
• OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 2
• 208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 2
• 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 2
• 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 2
• 229920002785 Croscarmellose sodium Polymers 0.000 description 2
• 235000003392 Curcuma domestica Nutrition 0.000 description 2
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
• AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
• GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 2
• ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
• 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
• 244000119298 Emblica officinalis Species 0.000 description 2
• 235000015489 Emblica officinalis Nutrition 0.000 description 2
• 208000007487 Familial Cerebral Amyloid Angiopathy Diseases 0.000 description 2
• 241000206672 Gelidium Species 0.000 description 2
• 235000011201 Ginkgo Nutrition 0.000 description 2
• 239000004471 Glycine Substances 0.000 description 2
• AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
• WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
• 208000032849 Hereditary cerebral hemorrhage with amyloidosis Diseases 0.000 description 2
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• 201000000162 ITM2B-related cerebral amyloid angiopathy 1 Diseases 0.000 description 2
• 201000000194 ITM2B-related cerebral amyloid angiopathy 2 Diseases 0.000 description 2
• 206010061218 Inflammation Diseases 0.000 description 2
• WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 description 2
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
• 239000005913 Maltodextrin Substances 0.000 description 2
• ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 2
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
• 208000026072 Motor neurone disease Diseases 0.000 description 2
• 208000001089 Multiple system atrophy Diseases 0.000 description 2
• WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
• JLEBZPBDRKPWTD-TURQNECASA-O N-ribosylnicotinamide Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)=C1 JLEBZPBDRKPWTD-TURQNECASA-O 0.000 description 2
• 241000772415 Neovison vison Species 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 241001494479 Pecora Species 0.000 description 2
• 208000000609 Pick Disease of the Brain Diseases 0.000 description 2
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
• 102000029797 Prion Human genes 0.000 description 2
• 108091000054 Prion Proteins 0.000 description 2
• RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
• ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
• 244000184734 Pyrus japonica Species 0.000 description 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
• PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
• PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
• MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
• GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
• GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
• 206010044688 Trisomy 21 Diseases 0.000 description 2
• 244000274883 Urtica dioica Species 0.000 description 2
• 235000009108 Urtica dioica Nutrition 0.000 description 2
• 235000009499 Vanilla fragrans Nutrition 0.000 description 2
• 244000263375 Vanilla tahitensis Species 0.000 description 2
• 235000012036 Vanilla tahitensis Nutrition 0.000 description 2
• 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 description 2
• FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
• 229930003268 Vitamin C Natural products 0.000 description 2
• 208000006269 X-Linked Bulbo-Spinal Atrophy Diseases 0.000 description 2
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
• 239000004480 active ingredient Substances 0.000 description 2
• 239000013543 active substance Substances 0.000 description 2
• 230000001154 acute effect Effects 0.000 description 2
• 125000004423 acyloxy group Chemical group 0.000 description 2
• 125000005042 acyloxymethyl group Chemical group 0.000 description 2
• 235000010419 agar Nutrition 0.000 description 2
• 235000010443 alginic acid Nutrition 0.000 description 2
• 229920000615 alginic acid Polymers 0.000 description 2
• 125000005193 alkenylcarbonyloxy group Chemical group 0.000 description 2
• 125000005092 alkenyloxycarbonyl group Chemical group 0.000 description 2
• 125000005136 alkenylsulfinyl group Chemical group 0.000 description 2
• 125000005206 alkoxycarbonyloxymethyl group Chemical group 0.000 description 2
• 125000005278 alkyl sulfonyloxy group Chemical group 0.000 description 2
• 125000004414 alkyl thio group Chemical group 0.000 description 2
• 125000005198 alkynylcarbonyloxy group Chemical group 0.000 description 2
• 125000005225 alkynyloxycarbonyl group Chemical group 0.000 description 2
• 125000005134 alkynylsulfinyl group Chemical group 0.000 description 2
• JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
• OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
• SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 2
• 125000000266 alpha-aminoacyl group Chemical group 0.000 description 2
• DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
• 125000003368 amide group Chemical group 0.000 description 2
• 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
• DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 description 2
• 235000010208 anthocyanin Nutrition 0.000 description 2
• 239000004410 anthocyanin Substances 0.000 description 2
• 229930002877 anthocyanin Natural products 0.000 description 2
• 150000004636 anthocyanins Chemical class 0.000 description 2
• 239000012062 aqueous buffer Substances 0.000 description 2
• YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
• 210000001367 artery Anatomy 0.000 description 2
• 206010003246 arthritis Diseases 0.000 description 2
• 125000005099 aryl alkyl carbonyl group Chemical group 0.000 description 2
• 125000004659 aryl alkyl thio group Chemical group 0.000 description 2
• 125000005129 aryl carbonyl group Chemical group 0.000 description 2
• 235000010323 ascorbic acid Nutrition 0.000 description 2
• 229960005070 ascorbic acid Drugs 0.000 description 2
• 239000011668 ascorbic acid Substances 0.000 description 2
• 208000006673 asthma Diseases 0.000 description 2
• 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 2
• 239000000440 bentonite Substances 0.000 description 2
• 229910000278 bentonite Inorganic materials 0.000 description 2
• SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
• SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
• QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 2
• YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 2
• 229940093265 berberine Drugs 0.000 description 2
• 239000011648 beta-carotene Substances 0.000 description 2
• 235000013734 beta-carotene Nutrition 0.000 description 2
• TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
• 229960002747 betacarotene Drugs 0.000 description 2
• 235000021029 blackberry Nutrition 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 208000005881 bovine spongiform encephalopathy Diseases 0.000 description 2
• 208000029028 brain injury Diseases 0.000 description 2
• FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
• 235000011092 calcium acetate Nutrition 0.000 description 2
• 239000001639 calcium acetate Substances 0.000 description 2
• 229960005147 calcium acetate Drugs 0.000 description 2
• 108010033929 calcium caseinate Proteins 0.000 description 2
• 229960002079 calcium pantothenate Drugs 0.000 description 2
• 125000001589 carboacyl group Chemical group 0.000 description 2
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
• 229960004203 carnitine Drugs 0.000 description 2
• 229940071162 caseinate Drugs 0.000 description 2
• 230000003833 cell viability Effects 0.000 description 2
• 235000010980 cellulose Nutrition 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 210000003169 central nervous system Anatomy 0.000 description 2
• 235000013339 cereals Nutrition 0.000 description 2
• 210000003710 cerebral cortex Anatomy 0.000 description 2
• 235000013351 cheese Nutrition 0.000 description 2
• 235000019693 cherries Nutrition 0.000 description 2
• 229940112822 chewing gum Drugs 0.000 description 2
• 235000015218 chewing gum Nutrition 0.000 description 2
• 235000019219 chocolate Nutrition 0.000 description 2
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
• 238000004587 chromatography analysis Methods 0.000 description 2
• QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 2
• 238000003776 cleavage reaction Methods 0.000 description 2
• 238000011260 co-administration Methods 0.000 description 2
• 239000005515 coenzyme Substances 0.000 description 2
• 235000017471 coenzyme Q10 Nutrition 0.000 description 2
• ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
• 235000016213 coffee Nutrition 0.000 description 2
• 235000013353 coffee beverage Nutrition 0.000 description 2
• 230000019771 cognition Effects 0.000 description 2
• 235000008504 concentrate Nutrition 0.000 description 2
• 239000012141 concentrate Substances 0.000 description 2
• 235000014510 cooky Nutrition 0.000 description 2
• 229940108925 copper gluconate Drugs 0.000 description 2
• 229910000365 copper sulfate Inorganic materials 0.000 description 2
• ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
• 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 2
• 235000012754 curcumin Nutrition 0.000 description 2
• 239000004148 curcumin Substances 0.000 description 2
• 229940109262 curcumin Drugs 0.000 description 2
• 229960002104 cyanocobalamin Drugs 0.000 description 2
• 235000000639 cyanocobalamin Nutrition 0.000 description 2
• 239000011666 cyanocobalamin Substances 0.000 description 2
• 230000001934 delay Effects 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
• 229940038472 dicalcium phosphate Drugs 0.000 description 2
• 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
• VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 2
• 238000010790 dilution Methods 0.000 description 2
• 239000012895 dilution Substances 0.000 description 2
• 230000006806 disease prevention Effects 0.000 description 2
• 239000007884 disintegrant Substances 0.000 description 2
• BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 2
• 239000002270 dispersing agent Substances 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• 229960003530 donepezil Drugs 0.000 description 2
• 239000008298 dragée Substances 0.000 description 2
• 150000002066 eicosanoids Chemical class 0.000 description 2
• 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
• JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
• 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
• 239000003792 electrolyte Substances 0.000 description 2
• 229920001968 ellagitannin Polymers 0.000 description 2
• 235000015897 energy drink Nutrition 0.000 description 2
• 230000002255 enzymatic effect Effects 0.000 description 2
• 229960005309 estradiol Drugs 0.000 description 2
• 229930182833 estradiol Natural products 0.000 description 2
• 239000002038 ethyl acetate fraction Substances 0.000 description 2
• 239000012091 fetal bovine serum Substances 0.000 description 2
• 239000000796 flavoring agent Substances 0.000 description 2
• 235000019634 flavors Nutrition 0.000 description 2
• 238000007667 floating Methods 0.000 description 2
• 235000012041 food component Nutrition 0.000 description 2
• 125000000524 functional group Chemical group 0.000 description 2
• 229960003980 galantamine Drugs 0.000 description 2
• ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 description 2
• 238000001030 gas--liquid chromatography Methods 0.000 description 2
• 210000001035 gastrointestinal tract Anatomy 0.000 description 2
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
• 235000005679 goldenseal Nutrition 0.000 description 2
• FFNTWLBZRJZJEJ-UHFFFAOYSA-N granatin B Natural products C=1C(=O)C(O)(O)C2(O)OC3=C(O)C(O)=CC(C(OC4C5OC(=O)C6=CC(O)=C(O)C(O)=C6C6=C(O)C(O)=C(O)C=C6C(=O)OCC4O4)=O)=C3C2C=1C(=O)OC5C4OC(=O)C1=CC(O)=C(O)C(O)=C1 FFNTWLBZRJZJEJ-UHFFFAOYSA-N 0.000 description 2
• 125000005203 haloalkylcarbonyloxy group Chemical group 0.000 description 2
• 230000008821 health effect Effects 0.000 description 2
• 239000000321 herbal drug Substances 0.000 description 2
• 125000005223 heteroarylcarbonyl group Chemical group 0.000 description 2
• 125000006517 heterocyclyl carbonyl group Chemical group 0.000 description 2
• 125000005844 heterocyclyloxy group Chemical group 0.000 description 2
• 150000002402 hexoses Chemical class 0.000 description 2
• 210000001320 hippocampus Anatomy 0.000 description 2
• 230000002209 hydrophobic effect Effects 0.000 description 2
• 239000012535 impurity Substances 0.000 description 2
• 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 2
• 239000003701 inert diluent Substances 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• 238000009434 installation Methods 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 150000002500 ions Chemical class 0.000 description 2
• 210000004558 lewy body Anatomy 0.000 description 2
• 238000004811 liquid chromatography Methods 0.000 description 2
• 239000008297 liquid dosage form Substances 0.000 description 2
• 235000021056 liquid food Nutrition 0.000 description 2
• 239000011777 magnesium Substances 0.000 description 2
• 229910052749 magnesium Inorganic materials 0.000 description 2
• 239000000395 magnesium oxide Substances 0.000 description 2
• CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
• 159000000003 magnesium salts Chemical class 0.000 description 2
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
• 235000019341 magnesium sulphate Nutrition 0.000 description 2
• 229940091250 magnesium supplement Drugs 0.000 description 2
• AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical class [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
• 238000012423 maintenance Methods 0.000 description 2
• 229940035034 maltodextrin Drugs 0.000 description 2
• 238000005259 measurement Methods 0.000 description 2
• 235000013372 meat Nutrition 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• BUGYDGFZZOZRHP-UHFFFAOYSA-N memantine Chemical compound C1C(C2)CC3(C)CC1(C)CC2(N)C3 BUGYDGFZZOZRHP-UHFFFAOYSA-N 0.000 description 2
• QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
• 229920000609 methyl cellulose Polymers 0.000 description 2
• 239000001923 methylcellulose Substances 0.000 description 2
• 235000010981 methylcellulose Nutrition 0.000 description 2
• 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
• 239000008108 microcrystalline cellulose Substances 0.000 description 2
• 229940016286 microcrystalline cellulose Drugs 0.000 description 2
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
• 229940029985 mineral supplement Drugs 0.000 description 2
• 235000020786 mineral supplement Nutrition 0.000 description 2
• 150000007522 mineralic acids Chemical class 0.000 description 2
• 230000009456 molecular mechanism Effects 0.000 description 2
• 208000005264 motor neuron disease Diseases 0.000 description 2
• 235000020772 multivitamin supplement Nutrition 0.000 description 2
• VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
• 230000016273 neuron death Effects 0.000 description 2
• 230000003557 neuropsychological effect Effects 0.000 description 2
• 235000005152 nicotinamide Nutrition 0.000 description 2
• 229960003966 nicotinamide Drugs 0.000 description 2
• 239000011570 nicotinamide Substances 0.000 description 2
• 235000020956 nicotinamide riboside Nutrition 0.000 description 2
• 239000011618 nicotinamide riboside Substances 0.000 description 2
• 235000001968 nicotinic acid Nutrition 0.000 description 2
• 229960003512 nicotinic acid Drugs 0.000 description 2
• 239000011664 nicotinic acid Substances 0.000 description 2
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
• 125000005151 nonafluorobutanesulfonyl group Chemical group FC(C(C(S(=O)(=O)*)(F)F)(F)F)(C(F)(F)F)F 0.000 description 2
• BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
• 235000020939 nutritional additive Nutrition 0.000 description 2
• 239000002674 ointment Substances 0.000 description 2
• 229920001542 oligosaccharide Polymers 0.000 description 2
• 150000002482 oligosaccharides Chemical class 0.000 description 2
• 239000004006 olive oil Substances 0.000 description 2
• 235000008390 olive oil Nutrition 0.000 description 2
• 239000006014 omega-3 oil Substances 0.000 description 2
• 238000007254 oxidation reaction Methods 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 230000001717 pathogenic effect Effects 0.000 description 2
• 230000003950 pathogenic mechanism Effects 0.000 description 2
• 230000007310 pathophysiology Effects 0.000 description 2
• 150000002972 pentoses Chemical class 0.000 description 2
• 230000006919 peptide aggregation Effects 0.000 description 2
• 210000000578 peripheral nerve Anatomy 0.000 description 2
• 235000021317 phosphate Nutrition 0.000 description 2
• WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
• 150000003904 phospholipids Chemical class 0.000 description 2
• SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
• MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 2
• 235000019175 phylloquinone Nutrition 0.000 description 2
• 239000011772 phylloquinone Substances 0.000 description 2
• 229960001898 phytomenadione Drugs 0.000 description 2
• 239000002798 polar solvent Substances 0.000 description 2
• 239000011591 potassium Substances 0.000 description 2
• 229910052700 potassium Inorganic materials 0.000 description 2
• 235000011056 potassium acetate Nutrition 0.000 description 2
• SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Substances [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
• 239000001103 potassium chloride Substances 0.000 description 2
• 235000011164 potassium chloride Nutrition 0.000 description 2
• 239000004302 potassium sorbate Substances 0.000 description 2
• 235000010241 potassium sorbate Nutrition 0.000 description 2
• 229940069338 potassium sorbate Drugs 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 230000003449 preventive effect Effects 0.000 description 2
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
• 229960004063 propylene glycol Drugs 0.000 description 2
• 230000012846 protein folding Effects 0.000 description 2
• 208000020016 psychiatric disease Diseases 0.000 description 2
• 235000011962 puddings Nutrition 0.000 description 2
• 238000000746 purification Methods 0.000 description 2
• ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
• 229960004172 pyridoxine hydrochloride Drugs 0.000 description 2
• 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 2
• 239000011764 pyridoxine hydrochloride Substances 0.000 description 2
• 238000011002 quantification Methods 0.000 description 2
• 235000021487 ready-to-eat food Nutrition 0.000 description 2
• 238000011084 recovery Methods 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 235000019192 riboflavin Nutrition 0.000 description 2
• 239000002151 riboflavin Substances 0.000 description 2
• 229960002477 riboflavin Drugs 0.000 description 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
• 235000015067 sauces Nutrition 0.000 description 2
• 230000007017 scission Effects 0.000 description 2
• 235000021057 semi-liquid food Nutrition 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 230000035939 shock Effects 0.000 description 2
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
• 239000011684 sodium molybdate Substances 0.000 description 2
• 235000015393 sodium molybdate Nutrition 0.000 description 2
• TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 2
• 239000011655 sodium selenate Substances 0.000 description 2
• 235000018716 sodium selenate Nutrition 0.000 description 2
• 229960001881 sodium selenate Drugs 0.000 description 2
• 239000011781 sodium selenite Substances 0.000 description 2
• 235000015921 sodium selenite Nutrition 0.000 description 2
• 229960001471 sodium selenite Drugs 0.000 description 2
• 239000008109 sodium starch glycolate Substances 0.000 description 2
• 229920003109 sodium starch glycolate Polymers 0.000 description 2
• 229940079832 sodium starch glycolate Drugs 0.000 description 2
• 235000014214 soft drink Nutrition 0.000 description 2
• 239000007909 solid dosage form Substances 0.000 description 2
• 239000000600 sorbitol Substances 0.000 description 2
• 210000000952 spleen Anatomy 0.000 description 2
• 239000007858 starting material Substances 0.000 description 2
• 150000003431 steroids Chemical class 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 230000004083 survival effect Effects 0.000 description 2
• 239000000375 suspending agent Substances 0.000 description 2
• 230000009182 swimming Effects 0.000 description 2
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
• 229960004860 thiamine mononitrate Drugs 0.000 description 2
• 235000019191 thiamine mononitrate Nutrition 0.000 description 2
• 239000011748 thiamine mononitrate Substances 0.000 description 2
• UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 2
• 239000002562 thickening agent Substances 0.000 description 2
• 125000001544 thienyl group Chemical group 0.000 description 2
• JADVWWSKYZXRGX-UHFFFAOYSA-M thioflavine T Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C1=[N+](C)C2=CC=C(C)C=C2S1 JADVWWSKYZXRGX-UHFFFAOYSA-M 0.000 description 2
• 125000003396 thiol group Chemical group [H]S* 0.000 description 2
• 125000004568 thiomorpholinyl group Chemical group 0.000 description 2
• 229930003802 tocotrienol Natural products 0.000 description 2
• 239000011731 tocotrienol Substances 0.000 description 2
• 235000019148 tocotrienols Nutrition 0.000 description 2
• 230000007704 transition Effects 0.000 description 2
• ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 2
• 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 description 2
• 239000013638 trimer Substances 0.000 description 2
• 235000013976 turmeric Nutrition 0.000 description 2
• 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
• 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
• 230000000007 visual effect Effects 0.000 description 2
• 235000019155 vitamin A Nutrition 0.000 description 2
• 239000011719 vitamin A Substances 0.000 description 2
• 235000019154 vitamin C Nutrition 0.000 description 2
• 239000011718 vitamin C Substances 0.000 description 2
• 229940045997 vitamin a Drugs 0.000 description 2
• 239000000341 volatile oil Substances 0.000 description 2
• 235000020234 walnut Nutrition 0.000 description 2
• 230000036642 wellbeing Effects 0.000 description 2
• 230000003936 working memory Effects 0.000 description 2
• NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
• 229910000368 zinc sulfate Inorganic materials 0.000 description 2
• 229960001763 zinc sulfate Drugs 0.000 description 2
• OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
• QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 2
• DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
• WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
• SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
• DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
• LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
• CBMYJHIOYJEBSB-DYSINSMMSA-N (5s,8r,9s,10s,13s,14s,17s)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,17-diol Chemical class C1C(O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 CBMYJHIOYJEBSB-DYSINSMMSA-N 0.000 description 1
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
• PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical class C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
• KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical class C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
• FIARMZDBEGVMLV-UHFFFAOYSA-N 1,1,2,2,2-pentafluoroethanolate Chemical group [O-]C(F)(F)C(F)(F)F FIARMZDBEGVMLV-UHFFFAOYSA-N 0.000 description 1
• JGTNAGYHADQMCM-UHFFFAOYSA-M 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate Chemical compound [O-]S(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F JGTNAGYHADQMCM-UHFFFAOYSA-M 0.000 description 1
• TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
• 229940058015 1,3-butylene glycol Drugs 0.000 description 1
• 125000005846 1-(alkanoyloxy)ethyl group Chemical group 0.000 description 1
• 125000005848 1-(alkoxycarbonyloxy)ethyl group Chemical group 0.000 description 1
• OQCYTSHIQNPJIC-QURGRASLSA-N 1-[(e)-2-bromo-1,2-diphenylethenyl]-4-ethylbenzene Chemical compound C1=CC(CC)=CC=C1C(\C=1C=CC=CC=1)=C(\Br)C1=CC=CC=C1 OQCYTSHIQNPJIC-QURGRASLSA-N 0.000 description 1
• HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
• 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
• 125000005847 1-methyl-1-(alkanoyloxy)-ethyl group Chemical group 0.000 description 1
• 125000005849 1-methyl-1-(alkoxycarbonyloxy)ethyl group Chemical group 0.000 description 1
• 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
• HCSBTDBGTNZOAB-UHFFFAOYSA-N 2,3-dinitrobenzoic acid Chemical compound OC(=O)C1=CC=CC([N+]([O-])=O)=C1[N+]([O-])=O HCSBTDBGTNZOAB-UHFFFAOYSA-N 0.000 description 1
• 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
• JNODDICFTDYODH-UHFFFAOYSA-N 2-hydroxytetrahydrofuran Chemical compound OC1CCCO1 JNODDICFTDYODH-UHFFFAOYSA-N 0.000 description 1
• 125000006022 2-methyl-2-propenyl group Chemical group 0.000 description 1
• 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
• 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
• HSTOKWSFWGCZMH-UHFFFAOYSA-N 3,3'-diaminobenzidine Chemical compound C1=C(N)C(N)=CC=C1C1=CC=C(N)C(N)=C1 HSTOKWSFWGCZMH-UHFFFAOYSA-N 0.000 description 1
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
• 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
• 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
• WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
• 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• AURFZBICLPNKBZ-YZRLXODZSA-N 3alpha-hydroxy-5beta-pregnan-20-one Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)C)[C@@]2(C)CC1 AURFZBICLPNKBZ-YZRLXODZSA-N 0.000 description 1
• OBKXEAXTFZPCHS-UHFFFAOYSA-N 4-phenylbutyric acid Chemical compound OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 description 1
• 125000006043 5-hexenyl group Chemical group 0.000 description 1
• GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
• 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
• 208000023769 AA amyloidosis Diseases 0.000 description 1
• 206010065040 AIDS dementia complex Diseases 0.000 description 1
• 241000208140 Acer Species 0.000 description 1
• WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
• NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
• 244000291564 Allium cepa Species 0.000 description 1
• 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
• 102100026882 Alpha-synuclein Human genes 0.000 description 1
• 239000005995 Aluminium silicate Substances 0.000 description 1
• 208000000044 Amnesia Diseases 0.000 description 1
• 208000031091 Amnestic disease Diseases 0.000 description 1
• 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
• 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
• 206010002023 Amyloidoses Diseases 0.000 description 1
• 102100032187 Androgen receptor Human genes 0.000 description 1
• 206010002383 Angina Pectoris Diseases 0.000 description 1
• 102000005666 Apolipoprotein A-I Human genes 0.000 description 1
• 108010059886 Apolipoprotein A-I Proteins 0.000 description 1
• 235000017060 Arachis glabrata Nutrition 0.000 description 1
• 244000105624 Arachis hypogaea Species 0.000 description 1
• 235000010777 Arachis hypogaea Nutrition 0.000 description 1
• 235000018262 Arachis monticola Nutrition 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 108010011485 Aspartame Proteins 0.000 description 1
• 102000014461 Ataxins Human genes 0.000 description 1
• 108010078286 Ataxins Proteins 0.000 description 1
• 201000001320 Atherosclerosis Diseases 0.000 description 1
• 101800001288 Atrial natriuretic factor Proteins 0.000 description 1
• 102400001282 Atrial natriuretic peptide Human genes 0.000 description 1
• 101800001890 Atrial natriuretic peptide Proteins 0.000 description 1
• 206010003694 Atrophy Diseases 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 235000016068 Berberis vulgaris Nutrition 0.000 description 1
• 240000000724 Berberis vulgaris Species 0.000 description 1
• ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
• 208000014644 Brain disease Diseases 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
• 206010068597 Bulbospinal muscular atrophy congenital Diseases 0.000 description 1
• COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
• DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
• DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 description 1
• 102000055006 Calcitonin Human genes 0.000 description 1
• 108060001064 Calcitonin Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241000222122 Candida albicans Species 0.000 description 1
• 244000025254 Cannabis sativa Species 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 239000004215 Carbon black (E152) Substances 0.000 description 1
• 206010007509 Cardiac amyloidosis Diseases 0.000 description 1
• 108010076119 Caseins Proteins 0.000 description 1
• 102000011632 Caseins Human genes 0.000 description 1
• 208000002177 Cataract Diseases 0.000 description 1
• 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
• 206010051290 Central nervous system lesion Diseases 0.000 description 1
• 206010008025 Cerebellar ataxia Diseases 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• 229940122041 Cholinesterase inhibitor Drugs 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 235000005979 Citrus limon Nutrition 0.000 description 1
• 244000131522 Citrus pyriformis Species 0.000 description 1
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
• 244000247747 Coptis groenlandica Species 0.000 description 1
• 235000002991 Coptis groenlandica Nutrition 0.000 description 1
• 229920000742 Cotton Polymers 0.000 description 1
• 241000195493 Cryptophyta Species 0.000 description 1
• 102000012192 Cystatin C Human genes 0.000 description 1
• 108010061642 Cystatin C Proteins 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• PNNNRSAQSRJVSB-JGWLITMVSA-N D-quinovose Chemical compound C[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-JGWLITMVSA-N 0.000 description 1
• YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 1
• FMGSKLZLMKYGDP-UHFFFAOYSA-N Dehydroepiandrosterone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 FMGSKLZLMKYGDP-UHFFFAOYSA-N 0.000 description 1
• 206010067889 Dementia with Lewy bodies Diseases 0.000 description 1
• XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
• 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
• 208000032928 Dyslipidaemia Diseases 0.000 description 1
• LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
• 208000032274 Encephalopathy Diseases 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
• 206010016207 Familial Mediterranean fever Diseases 0.000 description 1
• 108010049003 Fibrinogen Proteins 0.000 description 1
• 102000008946 Fibrinogen Human genes 0.000 description 1
• 102400000524 Fibrinogen alpha chain Human genes 0.000 description 1
• 101710137044 Fibrinogen alpha chain Proteins 0.000 description 1
• BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
• 235000016623 Fragaria vesca Nutrition 0.000 description 1
• 240000009088 Fragaria x ananassa Species 0.000 description 1
• 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
• 229940123457 Free radical scavenger Drugs 0.000 description 1
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
• 206010017533 Fungal infection Diseases 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
• 241000867624 Galinsoga mosaic virus Species 0.000 description 1
• 102000004878 Gelsolin Human genes 0.000 description 1
• 108090001064 Gelsolin Proteins 0.000 description 1
• 108010024636 Glutathione Proteins 0.000 description 1
• MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
• ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
• AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
• 241000219146 Gossypium Species 0.000 description 1
• 229920000067 Granatin A Polymers 0.000 description 1
• FFNTWLBZRJZJEJ-PYGBXMOSSA-N Granatin B Chemical compound O([C@H]1[C@@H]2OC(=O)C=3C4C5=C(C(O[C@H]6[C@@H]2OC(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(O)C=C2C(=O)OC[C@H]6O1)=O)C=C(C(=C5OC4(O)C(O)(O)C(=O)C=3)O)O)C(=O)C1=CC(O)=C(O)C(O)=C1 FFNTWLBZRJZJEJ-PYGBXMOSSA-N 0.000 description 1
• 229920002273 Granatin B Polymers 0.000 description 1
• 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
• 206010019196 Head injury Diseases 0.000 description 1
• 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
• 101000775732 Homo sapiens Androgen receptor Proteins 0.000 description 1
• 108091006905 Human Serum Albumin Proteins 0.000 description 1
• 102000008100 Human Serum Albumin Human genes 0.000 description 1
• ZRJBHWIHUMBLCN-SEQYCRGISA-N Huperzine A Natural products N1C(=O)C=CC2=C1C[C@H]1/C(=C/C)[C@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-SEQYCRGISA-N 0.000 description 1
• 241000735432 Hydrastis canadensis Species 0.000 description 1
• STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
• 235000017309 Hypericum perforatum Nutrition 0.000 description 1
• 244000141009 Hypericum perforatum Species 0.000 description 1
• 206010020772 Hypertension Diseases 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
• 102000013463 Immunoglobulin Light Chains Human genes 0.000 description 1
• 108010065825 Immunoglobulin Light Chains Proteins 0.000 description 1
• 208000005531 Immunoglobulin Light-chain Amyloidosis Diseases 0.000 description 1
• 201000008450 Intracranial aneurysm Diseases 0.000 description 1
• 102000004310 Ion Channels Human genes 0.000 description 1
• 241000758791 Juglandaceae Species 0.000 description 1
• 235000009496 Juglans regia Nutrition 0.000 description 1
• 240000007049 Juglans regia Species 0.000 description 1
• 208000027747 Kennedy disease Diseases 0.000 description 1
• 108010036762 Kolap Proteins 0.000 description 1
• QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
• 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
• FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• 201000002832 Lewy body dementia Diseases 0.000 description 1
• 208000017170 Lipid metabolism disease Diseases 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
• 240000003183 Manihot esculenta Species 0.000 description 1
• 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 235000010654 Melissa officinalis Nutrition 0.000 description 1
• 244000062730 Melissa officinalis Species 0.000 description 1
• 208000036626 Mental retardation Diseases 0.000 description 1
• 208000001145 Metabolic Syndrome Diseases 0.000 description 1
• 102000009664 Microtubule-Associated Proteins Human genes 0.000 description 1
• 108010020004 Microtubule-Associated Proteins Proteins 0.000 description 1
• 241000237852 Mollusca Species 0.000 description 1
• 229940123685 Monoamine oxidase inhibitor Drugs 0.000 description 1
• 108010014251 Muramidase Proteins 0.000 description 1
• 102000016943 Muramidase Human genes 0.000 description 1
• 208000031888 Mycoses Diseases 0.000 description 1
• 240000009023 Myrrhis odorata Species 0.000 description 1
• 235000007265 Myrrhis odorata Nutrition 0.000 description 1
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
• STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
• 208000029955 Nervous System Heredodegenerative disease Diseases 0.000 description 1
• 208000012902 Nervous system disease Diseases 0.000 description 1
• 208000025966 Neurological disease Diseases 0.000 description 1
• 206010029350 Neurotoxicity Diseases 0.000 description 1
• SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
• 239000000006 Nitroglycerin Substances 0.000 description 1
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
• 208000008589 Obesity Diseases 0.000 description 1
• 240000007817 Olea europaea Species 0.000 description 1
• 239000005642 Oleic acid Substances 0.000 description 1
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
• 206010053159 Organ failure Diseases 0.000 description 1
• 206010033307 Overweight Diseases 0.000 description 1
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
• 240000004371 Panax ginseng Species 0.000 description 1
• 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
• 235000003140 Panax quinquefolius Nutrition 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 102000003992 Peroxidases Human genes 0.000 description 1
• OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
• 240000008474 Pimenta dioica Species 0.000 description 1
• 235000012550 Pimpinella anisum Nutrition 0.000 description 1
• 241000404883 Pisa Species 0.000 description 1
• 229920005372 Plexiglas® Polymers 0.000 description 1
• 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
• 239000004952 Polyamide Substances 0.000 description 1
• 108010059820 Polygalacturonase Proteins 0.000 description 1
• 241000275475 Praia Species 0.000 description 1
• 108010071690 Prealbumin Proteins 0.000 description 1
• 102000007584 Prealbumin Human genes 0.000 description 1
• AURFZBICLPNKBZ-UHFFFAOYSA-N Pregnanolone Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(=O)C)C1(C)CC2 AURFZBICLPNKBZ-UHFFFAOYSA-N 0.000 description 1
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
• 102000007327 Protamines Human genes 0.000 description 1
• 108010007568 Protamines Proteins 0.000 description 1
• QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
• XSVMFMHYUFZWBK-NSHDSACASA-N Rivastigmine Chemical compound CCN(C)C(=O)OC1=CC=CC([C@H](C)N(C)C)=C1 XSVMFMHYUFZWBK-NSHDSACASA-N 0.000 description 1
• 235000011449 Rosa Nutrition 0.000 description 1
• 240000007651 Rubus glaucus Species 0.000 description 1
• 235000011034 Rubus glaucus Nutrition 0.000 description 1
• 235000009122 Rubus idaeus Nutrition 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 244000151637 Sambucus canadensis Species 0.000 description 1
• 235000018735 Sambucus canadensis Nutrition 0.000 description 1
• BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
• 206010039966 Senile dementia Diseases 0.000 description 1
• 108010071390 Serum Albumin Proteins 0.000 description 1
• 102000007562 Serum Albumin Human genes 0.000 description 1
• 102000054727 Serum Amyloid A Human genes 0.000 description 1
• 108700028909 Serum Amyloid A Proteins 0.000 description 1
• ZRJBHWIHUMBLCN-UHFFFAOYSA-N Shuangyiping Natural products N1C(=O)C=CC2=C1CC1C(=CC)C2(N)CC(C)=C1 ZRJBHWIHUMBLCN-UHFFFAOYSA-N 0.000 description 1
• 239000004283 Sodium sorbate Substances 0.000 description 1
• 235000002595 Solanum tuberosum Nutrition 0.000 description 1
• 244000061456 Solanum tuberosum Species 0.000 description 1
• 208000009415 Spinocerebellar Ataxias Diseases 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• 235000005729 Sterculia foetida Nutrition 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
• 102000019197 Superoxide Dismutase Human genes 0.000 description 1
• 108010012715 Superoxide dismutase Proteins 0.000 description 1
• 244000277583 Terminalia catappa Species 0.000 description 1
• 235000009319 Terminalia catappa Nutrition 0.000 description 1
• 235000011517 Terminalia chebula Nutrition 0.000 description 1
• UGAJKWZVPNVCIO-UHFFFAOYSA-N Terminalin Chemical compound O1C(=O)C(C2=3)=C(C4=C(O)C(O)=C(O)C=C4C(=O)O4)C4=C(O)C=3OC(=O)C3=C2C1=C(O)C(OC1=O)=C3C2=C1C=C(O)C(O)=C2O UGAJKWZVPNVCIO-UHFFFAOYSA-N 0.000 description 1
• QTNGLMWAVBOBLJ-UHFFFAOYSA-N Terminaline Natural products C1CC2C(O)C(O)CCC2(C)C2C1C1CCC(C(C)N(C)C)C1(C)CC2 QTNGLMWAVBOBLJ-UHFFFAOYSA-N 0.000 description 1
• 235000009470 Theobroma cacao Nutrition 0.000 description 1
• 208000007536 Thrombosis Diseases 0.000 description 1
• 206010044221 Toxic encephalopathy Diseases 0.000 description 1
• LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
• 235000021307 Triticum Nutrition 0.000 description 1
• 244000098338 Triticum aestivum Species 0.000 description 1
• 102000004142 Trypsin Human genes 0.000 description 1
• 108090000631 Trypsin Proteins 0.000 description 1
• 238000010162 Tukey test Methods 0.000 description 1
• DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 description 1
• 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
• 240000001717 Vaccinium macrocarpon Species 0.000 description 1
• 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
• 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
• 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
• 229920001938 Vegetable gum Polymers 0.000 description 1
• 241000863480 Vinca Species 0.000 description 1
• DDNCQMVWWZOMLN-IRLDBZIGSA-N Vinpocetine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C=C(C(=O)OCC)N5C2=C1 DDNCQMVWWZOMLN-IRLDBZIGSA-N 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 235000014787 Vitis vinifera Nutrition 0.000 description 1
• 240000006365 Vitis vinifera Species 0.000 description 1
• 235000019498 Walnut oil Nutrition 0.000 description 1
• 239000005862 Whey Substances 0.000 description 1
• 208000016463 Wild type ABeta2M amyloidosis Diseases 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• 241000736816 Xanthorhiza Species 0.000 description 1
• ZZXDRXVIRVJQBT-UHFFFAOYSA-M Xylenesulfonate Chemical compound CC1=CC=CC(S([O-])(=O)=O)=C1C ZZXDRXVIRVJQBT-UHFFFAOYSA-M 0.000 description 1
• 240000008042 Zea mays Species 0.000 description 1
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
• VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 description 1
• 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
• 239000002250 absorbent Substances 0.000 description 1
• 230000002745 absorbent Effects 0.000 description 1
• 239000003655 absorption accelerator Substances 0.000 description 1
• 235000003650 acai Nutrition 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 239000000619 acesulfame-K Substances 0.000 description 1
• 235000011054 acetic acid Nutrition 0.000 description 1
• IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
• 150000001243 acetic acids Chemical class 0.000 description 1
• 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
• OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
• 229960004373 acetylcholine Drugs 0.000 description 1
• 229960004308 acetylcysteine Drugs 0.000 description 1
• YTIVTFGABIZHHX-UHFFFAOYSA-L acetylenedicarboxylate(2-) Chemical compound [O-]C(=O)C#CC([O-])=O YTIVTFGABIZHHX-UHFFFAOYSA-L 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 239000012042 active reagent Substances 0.000 description 1
• 210000004100 adrenal gland Anatomy 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 238000012387 aerosolization Methods 0.000 description 1
• 230000007172 age related pathology Effects 0.000 description 1
• 125000003158 alcohol group Chemical group 0.000 description 1
• 235000013334 alcoholic beverage Nutrition 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 239000000783 alginic acid Substances 0.000 description 1
• 229960001126 alginic acid Drugs 0.000 description 1
• 150000004781 alginic acids Chemical class 0.000 description 1
• 125000001931 aliphatic group Chemical group 0.000 description 1
• 229910052783 alkali metal Inorganic materials 0.000 description 1
• 150000001340 alkali metals Chemical class 0.000 description 1
• 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
• 150000001342 alkaline earth metals Chemical class 0.000 description 1
• 229930013930 alkaloid Natural products 0.000 description 1
• 150000003797 alkaloid derivatives Chemical class 0.000 description 1
• 125000005137 alkenylsulfonyl group Chemical group 0.000 description 1
• 125000005108 alkenylthio group Chemical group 0.000 description 1
• 125000005138 alkoxysulfonyl group Chemical group 0.000 description 1
• 150000003973 alkyl amines Chemical class 0.000 description 1
• 125000003282 alkyl amino group Chemical group 0.000 description 1
• 125000005139 alkynylsulfonyl group Chemical group 0.000 description 1
• 125000005109 alkynylthio group Chemical group 0.000 description 1
• 229940100609 all-trans-retinol Drugs 0.000 description 1
• 239000011717 all-trans-retinol Substances 0.000 description 1
• 235000019169 all-trans-retinol Nutrition 0.000 description 1
• IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 description 1
• SHZGCJCMOBCMKK-DVKNGEFBSA-N alpha-D-quinovopyranose Chemical compound C[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-DVKNGEFBSA-N 0.000 description 1
• 108090000185 alpha-Synuclein Proteins 0.000 description 1
• 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• 235000012211 aluminium silicate Nutrition 0.000 description 1
• CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
• 229940024548 aluminum oxide Drugs 0.000 description 1
• 229940063655 aluminum stearate Drugs 0.000 description 1
• PLOPBXQQPZYQFA-AXPWDRQUSA-N amlintide Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)CSSC1)[C@@H](C)O)C(C)C)C1=CC=CC=C1 PLOPBXQQPZYQFA-AXPWDRQUSA-N 0.000 description 1
• 229910021529 ammonia Inorganic materials 0.000 description 1
• 230000006986 amnesia Effects 0.000 description 1
• 230000006933 amyloid-beta aggregation Effects 0.000 description 1
• AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 description 1
• 229960005471 androstenedione Drugs 0.000 description 1
• AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 description 1
• 235000019728 animal nutrition Nutrition 0.000 description 1
• 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
• 230000003627 anti-cholesterol Effects 0.000 description 1
• 229940121363 anti-inflammatory agent Drugs 0.000 description 1
• 239000002260 anti-inflammatory agent Substances 0.000 description 1
• 230000003110 anti-inflammatory effect Effects 0.000 description 1
• 235000015197 apple juice Nutrition 0.000 description 1
• 239000012223 aqueous fraction Substances 0.000 description 1
• 239000007900 aqueous suspension Substances 0.000 description 1
• 239000008135 aqueous vehicle Substances 0.000 description 1
• 229940114079 arachidonic acid Drugs 0.000 description 1
• 235000021342 arachidonic acid Nutrition 0.000 description 1
• 125000005140 aralkylsulfonyl group Chemical group 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 238000000149 argon plasma sintering Methods 0.000 description 1
• 239000008122 artificial sweetener Substances 0.000 description 1
• 235000021311 artificial sweeteners Nutrition 0.000 description 1
• 125000005251 aryl acyl group Chemical group 0.000 description 1
• 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 1
• 125000005199 aryl carbonyloxy group Chemical group 0.000 description 1
• 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
• 125000005142 aryl oxy sulfonyl group Chemical group 0.000 description 1
• 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
• 125000005279 aryl sulfonyloxy group Chemical group 0.000 description 1
• 125000005110 aryl thio group Chemical group 0.000 description 1
• 125000000732 arylene group Chemical group 0.000 description 1
• 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
• 239000000605 aspartame Substances 0.000 description 1
• IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
• 235000010357 aspartame Nutrition 0.000 description 1
• 229960003438 aspartame Drugs 0.000 description 1
• 238000011914 asymmetric synthesis Methods 0.000 description 1
• 239000012298 atmosphere Substances 0.000 description 1
• 230000001746 atrial effect Effects 0.000 description 1
• 230000037444 atrophy Effects 0.000 description 1
• 201000004562 autosomal dominant cerebellar ataxia Diseases 0.000 description 1
• 125000005334 azaindolyl group Chemical group N1N=C(C2=CC=CC=C12)* 0.000 description 1
• 150000001538 azepines Chemical class 0.000 description 1
• 125000002393 azetidinyl group Chemical group 0.000 description 1
• 235000008452 baby food Nutrition 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
• 229940002010 banana extract Drugs 0.000 description 1
• 239000010620 bay oil Substances 0.000 description 1
• 238000009227 behaviour therapy Methods 0.000 description 1
• 230000003542 behavioural effect Effects 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
• 229940050390 benzoate Drugs 0.000 description 1
• 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
• 235000010233 benzoic acid Nutrition 0.000 description 1
• 150000001559 benzoic acids Chemical class 0.000 description 1
• 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
• 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
• 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
• 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
• 229960002903 benzyl benzoate Drugs 0.000 description 1
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
• 235000021028 berry Nutrition 0.000 description 1
• 229940066595 beta tocopherol Drugs 0.000 description 1
• 239000013060 biological fluid Substances 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 235000010290 biphenyl Nutrition 0.000 description 1
• 239000004305 biphenyl Substances 0.000 description 1
• 125000006267 biphenyl group Chemical group 0.000 description 1
• 230000004397 blinking Effects 0.000 description 1
• 229920001400 block copolymer Polymers 0.000 description 1
• 210000004204 blood vessel Anatomy 0.000 description 1
• 235000007123 blue elder Nutrition 0.000 description 1
• 235000021014 blueberries Nutrition 0.000 description 1
• 230000036760 body temperature Effects 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 208000021138 brain aneurysm Diseases 0.000 description 1
• 210000004958 brain cell Anatomy 0.000 description 1
• 230000006931 brain damage Effects 0.000 description 1
• 231100000874 brain damage Toxicity 0.000 description 1
• 230000003925 brain function Effects 0.000 description 1
• 235000008429 bread Nutrition 0.000 description 1
• 239000007853 buffer solution Substances 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• 244000309464 bull Species 0.000 description 1
• 239000001273 butane Substances 0.000 description 1
• 235000019437 butane-1,3-diol Nutrition 0.000 description 1
• 239000002034 butanolic fraction Substances 0.000 description 1
• 235000012970 cakes Nutrition 0.000 description 1
• BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
• 229960004015 calcitonin Drugs 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 229960003563 calcium carbonate Drugs 0.000 description 1
• 239000001201 calcium disodium ethylene diamine tetra-acetate Substances 0.000 description 1
• 235000011188 calcium disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
• 235000012241 calcium silicate Nutrition 0.000 description 1
• CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
• 235000013539 calcium stearate Nutrition 0.000 description 1
• 239000008116 calcium stearate Substances 0.000 description 1
• SHWNNYZBHZIQQV-UHFFFAOYSA-L calcium;disodium;2-[2-[bis(carboxylatomethyl)azaniumyl]ethyl-(carboxylatomethyl)azaniumyl]acetate Chemical compound [Na+].[Na+].[Ca+2].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC([O-])=O)CC([O-])=O SHWNNYZBHZIQQV-UHFFFAOYSA-L 0.000 description 1
• 229940095731 candida albicans Drugs 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 125000005586 carbonic acid group Chemical group 0.000 description 1
• 150000001735 carboxylic acids Chemical class 0.000 description 1
• 229940105329 carboxymethylcellulose Drugs 0.000 description 1
• NSQLIUXCMFBZME-MPVJKSABSA-N carperitide Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 NSQLIUXCMFBZME-MPVJKSABSA-N 0.000 description 1
• 239000004359 castor oil Substances 0.000 description 1
• 235000019438 castor oil Nutrition 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 239000003054 catalyst Substances 0.000 description 1
• 150000001765 catechin Chemical class 0.000 description 1
• ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
• 235000005487 catechin Nutrition 0.000 description 1
• 239000010627 cedar oil Substances 0.000 description 1
• 230000004098 cellular respiration Effects 0.000 description 1
• 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
• 208000026106 cerebrovascular disease Diseases 0.000 description 1
• 229910052729 chemical element Inorganic materials 0.000 description 1
• 238000001311 chemical methods and process Methods 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• KVSASDOGYIBWTA-UHFFFAOYSA-N chloro benzoate Chemical compound ClOC(=O)C1=CC=CC=C1 KVSASDOGYIBWTA-UHFFFAOYSA-N 0.000 description 1
• 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
• 208000037976 chronic inflammation Diseases 0.000 description 1
• 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
• 239000010630 cinnamon oil Substances 0.000 description 1
• 235000015165 citric acid Nutrition 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
• 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
• 239000004927 clay Substances 0.000 description 1
• 238000004140 cleaning Methods 0.000 description 1
• 238000003759 clinical diagnosis Methods 0.000 description 1
• 239000010634 clove oil Substances 0.000 description 1
• 229920006026 co-polymeric resin Polymers 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• 230000037410 cognitive enhancement Effects 0.000 description 1
• 230000003920 cognitive function Effects 0.000 description 1
• 231100000870 cognitive problem Toxicity 0.000 description 1
• 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 239000000306 component Substances 0.000 description 1
• 239000007891 compressed tablet Substances 0.000 description 1
• 238000007906 compression Methods 0.000 description 1
• 230000006835 compression Effects 0.000 description 1
• IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
• 238000007596 consolidation process Methods 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• 235000005822 corn Nutrition 0.000 description 1
• 210000004087 cornea Anatomy 0.000 description 1
• 235000004634 cranberry Nutrition 0.000 description 1
• 229960001681 croscarmellose sodium Drugs 0.000 description 1
• 229960000913 crospovidone Drugs 0.000 description 1
• 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 235000021438 curry Nutrition 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 150000003999 cyclitols Chemical class 0.000 description 1
• 150000001924 cycloalkanes Chemical class 0.000 description 1
• HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical class OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
• 231100000135 cytotoxicity Toxicity 0.000 description 1
• 230000003013 cytotoxicity Effects 0.000 description 1
• 235000019543 dairy drink Nutrition 0.000 description 1
• 235000013365 dairy product Nutrition 0.000 description 1
• GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
• GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 1
• 239000003405 delayed action preparation Substances 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 235000010389 delta-tocopherol Nutrition 0.000 description 1
• CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
• 230000006866 deterioration Effects 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 230000000378 dietary effect Effects 0.000 description 1
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
• 235000019621 digestibility Nutrition 0.000 description 1
• FSBVERYRVPGNGG-UHFFFAOYSA-N dimagnesium dioxido-bis[[oxido(oxo)silyl]oxy]silane hydrate Chemical compound O.[Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O FSBVERYRVPGNGG-UHFFFAOYSA-N 0.000 description 1
• 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
• XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
• 235000011180 diphosphates Nutrition 0.000 description 1
• 150000002016 disaccharides Chemical class 0.000 description 1
• 208000037765 diseases and disorders Diseases 0.000 description 1
• BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
• 238000004090 dissolution Methods 0.000 description 1
• 239000012153 distilled water Substances 0.000 description 1
• RXPRRQLKFXBCSJ-UHFFFAOYSA-N dl-Vincamin Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-UHFFFAOYSA-N 0.000 description 1
• 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
• KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
• 230000035622 drinking Effects 0.000 description 1
• 230000002526 effect on cardiovascular system Effects 0.000 description 1
• 235000007124 elderberry Nutrition 0.000 description 1
• 229950007402 eltanolone Drugs 0.000 description 1
• 239000003974 emollient agent Substances 0.000 description 1
• 230000002124 endocrine Effects 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 229940088598 enzyme Drugs 0.000 description 1
• 229940030275 epigallocatechin gallate Drugs 0.000 description 1
• 206010015037 epilepsy Diseases 0.000 description 1
• 235000019414 erythritol Nutrition 0.000 description 1
• 239000003797 essential amino acid Substances 0.000 description 1
• 235000020776 essential amino acid Nutrition 0.000 description 1
• 235000020774 essential nutrients Nutrition 0.000 description 1
• 230000032050 esterification Effects 0.000 description 1
• 238000005886 esterification reaction Methods 0.000 description 1
• 229940011871 estrogen Drugs 0.000 description 1
• 239000000262 estrogen Substances 0.000 description 1
• 229960003399 estrone Drugs 0.000 description 1
• BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
• 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
• VFRSADQPWYCXDG-LEUCUCNGSA-N ethyl (2s,5s)-5-methylpyrrolidine-2-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCOC(=O)[C@@H]1CC[C@H](C)N1 VFRSADQPWYCXDG-LEUCUCNGSA-N 0.000 description 1
• 229940093499 ethyl acetate Drugs 0.000 description 1
• LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
• 229940093471 ethyl oleate Drugs 0.000 description 1
• 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
• 235000008995 european elder Nutrition 0.000 description 1
• 230000005284 excitation Effects 0.000 description 1
• 108010093305 exopolygalacturonase Proteins 0.000 description 1
• 239000003889 eye drop Substances 0.000 description 1
• 229940012356 eye drops Drugs 0.000 description 1
• 239000003885 eye ointment Substances 0.000 description 1
• 201000007891 familial visceral amyloidosis Diseases 0.000 description 1
• 201000006061 fatal familial insomnia Diseases 0.000 description 1
• 230000002349 favourable effect Effects 0.000 description 1
• 239000012894 fetal calf serum Substances 0.000 description 1
• 229940012952 fibrinogen Drugs 0.000 description 1
• 239000012467 final product Substances 0.000 description 1
• 229930003935 flavonoid Natural products 0.000 description 1
• 150000002215 flavonoids Chemical class 0.000 description 1
• 235000017173 flavonoids Nutrition 0.000 description 1
• 238000001506 fluorescence spectroscopy Methods 0.000 description 1
• 125000001153 fluoro group Chemical group F* 0.000 description 1
• 125000004428 fluoroalkoxy group Chemical group 0.000 description 1
• NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
• 239000006260 foam Substances 0.000 description 1
• 239000010200 folin Substances 0.000 description 1
• 239000005417 food ingredient Substances 0.000 description 1
• 235000010855 food raising agent Nutrition 0.000 description 1
• 238000012048 forced swim test Methods 0.000 description 1
• 239000003205 fragrance Substances 0.000 description 1
• 239000012458 free base Substances 0.000 description 1
• 238000004108 freeze drying Methods 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• 230000008014 freezing Effects 0.000 description 1
• 235000015203 fruit juice Nutrition 0.000 description 1
• 125000002541 furyl group Chemical group 0.000 description 1
• 102000013069 gamma-Crystallins Human genes 0.000 description 1
• 108010079934 gamma-Crystallins Proteins 0.000 description 1
• 235000010382 gamma-tocopherol Nutrition 0.000 description 1
• 239000002223 garnet Substances 0.000 description 1
• 235000008434 ginseng Nutrition 0.000 description 1
• 229960001031 glucose Drugs 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
• SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
• 229960003711 glyceryl trinitrate Drugs 0.000 description 1
• 229960002449 glycine Drugs 0.000 description 1
• 125000003147 glycosyl group Chemical group 0.000 description 1
• GSZXURISMHFXFN-UHFFFAOYSA-N granatin A Natural products OC1C2OC(=O)c3cc(O)c(O)c4OC5(O)C(C(=CC(=O)C5(O)O)C(=O)OC1C6OC2COC(=O)c7cc(O)c(O)c(O)c7c8c(O)c(O)c(O)cc8C(=O)O6)c34 GSZXURISMHFXFN-UHFFFAOYSA-N 0.000 description 1
• BEAQEKRAXFQCBO-UHFFFAOYSA-N granatin a Chemical compound O1C(C(C2O)OC(=O)C3=CC(O)=C4O)COC(=O)C5=CC(O)=C(O)C(O)=C5C5=C(O)C(O)=C(O)C=C5C(=O)C1C2OC(=O)C1=CC(=O)C2(O)OC4=C3C1C2(O)O BEAQEKRAXFQCBO-UHFFFAOYSA-N 0.000 description 1
• 235000002532 grape seed extract Nutrition 0.000 description 1
• 235000015201 grapefruit juice Nutrition 0.000 description 1
• 244000144993 groups of animals Species 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 238000001631 haemodialysis Methods 0.000 description 1
• 125000004438 haloalkoxy group Chemical group 0.000 description 1
• 125000004440 haloalkylsulfinyl group Chemical group 0.000 description 1
• 125000004441 haloalkylsulfonyl group Chemical group 0.000 description 1
• 125000004995 haloalkylthio group Chemical group 0.000 description 1
• 125000005843 halogen group Chemical group 0.000 description 1
• 210000003128 head Anatomy 0.000 description 1
• 235000013402 health food Nutrition 0.000 description 1
• 230000037219 healthy weight Effects 0.000 description 1
• 208000019622 heart disease Diseases 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 230000000322 hemodialysis Effects 0.000 description 1
• MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
• 241000411851 herbal medicine Species 0.000 description 1
• 235000008216 herbs Nutrition 0.000 description 1
• 125000005367 heteroarylalkylthio group Chemical group 0.000 description 1
• 125000005204 heteroarylcarbonyloxy group Chemical group 0.000 description 1
• 125000005549 heteroarylene group Chemical group 0.000 description 1
• 125000005226 heteroaryloxycarbonyl group Chemical group 0.000 description 1
• 125000005143 heteroarylsulfonyl group Chemical group 0.000 description 1
• 125000005368 heteroarylthio group Chemical group 0.000 description 1
• 125000004468 heterocyclylthio group Chemical group 0.000 description 1
• 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 239000003906 humectant Substances 0.000 description 1
• ZRJBHWIHUMBLCN-YQEJDHNASA-N huperzine A Chemical compound N1C(=O)C=CC2=C1C[C@H]1\C(=C/C)[C@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-YQEJDHNASA-N 0.000 description 1
• XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
• 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
• UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
• 201000001421 hyperglycemia Diseases 0.000 description 1
• 235000015243 ice cream Nutrition 0.000 description 1
• JGPMMRGNQUBGND-UHFFFAOYSA-N idebenone Chemical compound COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O JGPMMRGNQUBGND-UHFFFAOYSA-N 0.000 description 1
• 229960004135 idebenone Drugs 0.000 description 1
• 125000002883 imidazolyl group Chemical group 0.000 description 1
• 125000004857 imidazopyridinyl group Chemical group N1C(=NC2=C1C=CC=N2)* 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 230000010057 immune-inflammatory process Effects 0.000 description 1
• 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
• 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
• 125000001041 indolyl group Chemical group 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 230000008798 inflammatory stress Effects 0.000 description 1
• 230000004941 influx Effects 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 150000004001 inositols Chemical class 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000005342 ion exchange Methods 0.000 description 1
• 208000028867 ischemia Diseases 0.000 description 1
• 210000004153 islets of langerhan Anatomy 0.000 description 1
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
• KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
• CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
• 150000002515 isoflavone derivatives Chemical class 0.000 description 1
• 235000008696 isoflavones Nutrition 0.000 description 1
• 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
• 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 229930013397 isoquinoline alkaloid Natural products 0.000 description 1
• 125000002183 isoquinolinyl group Chemical class C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
• 239000000644 isotonic solution Substances 0.000 description 1
• 238000010902 jet-milling Methods 0.000 description 1
• 210000001503 joint Anatomy 0.000 description 1
• 230000000366 juvenile effect Effects 0.000 description 1
• NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
• BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
• WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
• 229960004705 kojic acid Drugs 0.000 description 1
• 206010023497 kuru Diseases 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 229960001375 lactose Drugs 0.000 description 1
• 235000015122 lemonade Nutrition 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 150000002617 leukotrienes Chemical class 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 229960004488 linolenic acid Drugs 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 239000012669 liquid formulation Substances 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 235000010335 lysozyme Nutrition 0.000 description 1
• 239000004325 lysozyme Substances 0.000 description 1
• 229960000274 lysozyme Drugs 0.000 description 1
• 238000002803 maceration Methods 0.000 description 1
• UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
• 239000011654 magnesium acetate Substances 0.000 description 1
• 235000011285 magnesium acetate Nutrition 0.000 description 1
• 229940069446 magnesium acetate Drugs 0.000 description 1
• 229910001629 magnesium chloride Inorganic materials 0.000 description 1
• 239000004337 magnesium citrate Substances 0.000 description 1
• 229960005336 magnesium citrate Drugs 0.000 description 1
• 235000002538 magnesium citrate Nutrition 0.000 description 1
• 239000001755 magnesium gluconate Substances 0.000 description 1
• 235000015778 magnesium gluconate Nutrition 0.000 description 1
• 229960003035 magnesium gluconate Drugs 0.000 description 1
• OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 description 1
• 239000000626 magnesium lactate Substances 0.000 description 1
• 235000015229 magnesium lactate Nutrition 0.000 description 1
• 229960004658 magnesium lactate Drugs 0.000 description 1
• 239000000391 magnesium silicate Substances 0.000 description 1
• 229940057948 magnesium stearate Drugs 0.000 description 1
• 229940099273 magnesium trisilicate Drugs 0.000 description 1
• 235000019793 magnesium trisilicate Nutrition 0.000 description 1
• 229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
• IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
• 239000011976 maleic acid Substances 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 239000008268 mayonnaise Substances 0.000 description 1
• 235000010746 mayonnaise Nutrition 0.000 description 1
• 238000002483 medication Methods 0.000 description 1
• 208000023356 medullary thyroid gland carcinoma Diseases 0.000 description 1
• 229960004640 memantine Drugs 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 210000004379 membrane Anatomy 0.000 description 1
• 230000006883 memory enhancing effect Effects 0.000 description 1
• 230000007334 memory performance Effects 0.000 description 1
• 230000003923 mental ability Effects 0.000 description 1
• 230000004630 mental health Effects 0.000 description 1
• 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• 125000005341 metaphosphate group Chemical group 0.000 description 1
• 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
• IZYBEMGNIUSSAX-UHFFFAOYSA-N methyl benzenecarboperoxoate Chemical compound COOC(=O)C1=CC=CC=C1 IZYBEMGNIUSSAX-UHFFFAOYSA-N 0.000 description 1
• 229940095102 methyl benzoate Drugs 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 229960002900 methylcellulose Drugs 0.000 description 1
• 239000004530 micro-emulsion Substances 0.000 description 1
• 230000002906 microbiologic effect Effects 0.000 description 1
• 239000003094 microcapsule Substances 0.000 description 1
• 235000013384 milk substitute Nutrition 0.000 description 1
• 235000020166 milkshake Nutrition 0.000 description 1
• 229940105902 mint extract Drugs 0.000 description 1
• 230000000116 mitigating effect Effects 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 239000007932 molded tablet Substances 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 239000002899 monoamine oxidase inhibitor Substances 0.000 description 1
• CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
• 125000005858 morpholino(C2-C3)alkyl group Chemical group 0.000 description 1
• 125000002757 morpholinyl group Chemical group 0.000 description 1
• 201000003152 motion sickness Diseases 0.000 description 1
• 230000007659 motor function Effects 0.000 description 1
• 238000000465 moulding Methods 0.000 description 1
• 239000012120 mounting media Substances 0.000 description 1
• 210000004400 mucous membrane Anatomy 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 208000010125 myocardial infarction Diseases 0.000 description 1
• IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
• OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
• 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 229940033872 namenda Drugs 0.000 description 1
• 239000002088 nanocapsule Substances 0.000 description 1
• PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
• KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
• 125000001624 naphthyl group Chemical group 0.000 description 1
• 239000007922 nasal spray Substances 0.000 description 1
• 229930014626 natural product Natural products 0.000 description 1
• 230000017066 negative regulation of growth Effects 0.000 description 1
• 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 230000007830 nerve conduction Effects 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• 239000004090 neuroprotective agent Substances 0.000 description 1
• 230000000324 neuroprotective effect Effects 0.000 description 1
• 231100000228 neurotoxicity Toxicity 0.000 description 1
• 239000002858 neurotransmitter agent Substances 0.000 description 1
• 238000006386 neutralization reaction Methods 0.000 description 1
• 229960002715 nicotine Drugs 0.000 description 1
• SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
• 235000019520 non-alcoholic beverage Nutrition 0.000 description 1
• 125000006574 non-aromatic ring group Chemical group 0.000 description 1
• 231100000344 non-irritating Toxicity 0.000 description 1
• 239000012457 nonaqueous media Substances 0.000 description 1
• 239000002687 nonaqueous vehicle Substances 0.000 description 1
• 239000002736 nonionic surfactant Substances 0.000 description 1
• 231100000956 nontoxicity Toxicity 0.000 description 1
• 235000014571 nuts Nutrition 0.000 description 1
• 235000020824 obesity Nutrition 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
• WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
• 238000001543 one-way ANOVA Methods 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 235000015205 orange juice Nutrition 0.000 description 1
• 239000007800 oxidant agent Substances 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 230000001590 oxidative effect Effects 0.000 description 1
• 230000004783 oxidative metabolism Effects 0.000 description 1
• TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
• 125000005476 oxopyrrolidinyl group Chemical group 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• 235000021485 packed food Nutrition 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
• 239000012188 paraffin wax Substances 0.000 description 1
• 244000045947 parasite Species 0.000 description 1
• 238000004810 partition chromatography Methods 0.000 description 1
• 238000011302 passive avoidance test Methods 0.000 description 1
• 235000015927 pasta Nutrition 0.000 description 1
• 235000010603 pastilles Nutrition 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 235000020232 peanut Nutrition 0.000 description 1
• 235000021400 peanut butter Nutrition 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
• 235000019477 peppermint oil Nutrition 0.000 description 1
• 238000011056 performance test Methods 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 229940021222 peritoneal dialysis isotonic solution Drugs 0.000 description 1
• 108040007629 peroxidase activity proteins Proteins 0.000 description 1
• 239000008177 pharmaceutical agent Substances 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
• DYUMLJSJISTVPV-UHFFFAOYSA-N phenyl propanoate Chemical compound CCC(=O)OC1=CC=CC=C1 DYUMLJSJISTVPV-UHFFFAOYSA-N 0.000 description 1
• WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
• 229940049953 phenylacetate Drugs 0.000 description 1
• WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
• ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
• 229950009215 phenylbutanoic acid Drugs 0.000 description 1
• 208000028591 pheochromocytoma Diseases 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 239000008363 phosphate buffer Substances 0.000 description 1
• 235000011007 phosphoric acid Nutrition 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• 150000003016 phosphoric acids Chemical class 0.000 description 1
• 229910052698 phosphorus Inorganic materials 0.000 description 1
• 239000011574 phosphorus Substances 0.000 description 1
• XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 239000003075 phytoestrogen Substances 0.000 description 1
• 229940013712 pineapple extract Drugs 0.000 description 1
• 125000004193 piperazinyl group Chemical group 0.000 description 1
• 125000005856 piperidino(C2-C3)alkyl group Chemical group 0.000 description 1
• 125000003386 piperidinyl group Chemical group 0.000 description 1
• 239000000419 plant extract Substances 0.000 description 1
• 229920000058 polyacrylate Polymers 0.000 description 1
• 229920002647 polyamide Polymers 0.000 description 1
• 125000003367 polycyclic group Chemical group 0.000 description 1
• 108010040003 polyglutamine Proteins 0.000 description 1
• 229920000155 polyglutamine Polymers 0.000 description 1
• 239000004926 polymethyl methacrylate Substances 0.000 description 1
• 229920005862 polyol Polymers 0.000 description 1
• 150000003077 polyols Chemical class 0.000 description 1
• 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
• 229920001184 polypeptide Polymers 0.000 description 1
• 229920001296 polysiloxane Polymers 0.000 description 1
• 229920003053 polystyrene-divinylbenzene Polymers 0.000 description 1
• 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
• 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 235000021395 porridge Nutrition 0.000 description 1
• XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
• 235000010235 potassium benzoate Nutrition 0.000 description 1
• 239000004300 potassium benzoate Substances 0.000 description 1
• 229940103091 potassium benzoate Drugs 0.000 description 1
• 229940069328 povidone Drugs 0.000 description 1
• 229960002847 prasterone Drugs 0.000 description 1
• 238000004321 preservation Methods 0.000 description 1
• 230000002335 preservative effect Effects 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 239000000186 progesterone Substances 0.000 description 1
• 229960003387 progesterone Drugs 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• UFUASNAHBMBJIX-UHFFFAOYSA-N propan-1-one Chemical group CC[C]=O UFUASNAHBMBJIX-UHFFFAOYSA-N 0.000 description 1
• 239000001294 propane Substances 0.000 description 1
• KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
• 238000011321 prophylaxis Methods 0.000 description 1
• 235000013772 propylene glycol Nutrition 0.000 description 1
• 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
• UORVCLMRJXCDCP-UHFFFAOYSA-M propynoate Chemical compound [O-]C(=O)C#C UORVCLMRJXCDCP-UHFFFAOYSA-M 0.000 description 1
• 150000003180 prostaglandins Chemical class 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 229950008679 protamine sulfate Drugs 0.000 description 1
• 230000009822 protein phosphorylation Effects 0.000 description 1
• 239000003586 protic polar solvent Substances 0.000 description 1
• 239000001575 punica granatum l. bark extract Substances 0.000 description 1
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
• 125000005857 pyrrolidino(C2-C3)alkyl group Chemical group 0.000 description 1
• 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
• 239000010453 quartz Substances 0.000 description 1
• 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
• 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
• 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 description 1
• ZRJBHWIHUMBLCN-BMIGLBTASA-N rac-huperzine A Natural products N1C(=O)C=CC2=C1C[C@@H]1C(=CC)[C@@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-BMIGLBTASA-N 0.000 description 1
• 239000002516 radical scavenger Substances 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
• 230000003014 reinforcing effect Effects 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 235000021283 resveratrol Nutrition 0.000 description 1
• 229940016667 resveratrol Drugs 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 125000006413 ring segment Chemical group 0.000 description 1
• 229960004136 rivastigmine Drugs 0.000 description 1
• 229960001860 salicylate Drugs 0.000 description 1
• 229960004889 salicylic acid Drugs 0.000 description 1
• 201000000980 schizophrenia Diseases 0.000 description 1
• STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
• 229960002646 scopolamine Drugs 0.000 description 1
• 208000008864 scrapie Diseases 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 238000012106 screening analysis Methods 0.000 description 1
• CDAISMWEOUEBRE-CDRYSYESSA-N scyllo-inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O CDAISMWEOUEBRE-CDRYSYESSA-N 0.000 description 1
• 229940116351 sebacate Drugs 0.000 description 1
• CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 1
• MEZLKOACVSPNER-UHFFFAOYSA-N selegiline Chemical compound C#CCN(C)C(C)CC1=CC=CC=C1 MEZLKOACVSPNER-UHFFFAOYSA-N 0.000 description 1
• 229910052711 selenium Inorganic materials 0.000 description 1
• 239000011669 selenium Substances 0.000 description 1
• 229940091258 selenium supplement Drugs 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 238000010008 shearing Methods 0.000 description 1
• 230000008054 signal transmission Effects 0.000 description 1
• 150000004760 silicates Chemical class 0.000 description 1
• 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
• 235000021309 simple sugar Nutrition 0.000 description 1
• 210000000813 small intestine Anatomy 0.000 description 1
• 230000005586 smoking cessation Effects 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
• 235000010234 sodium benzoate Nutrition 0.000 description 1
• 239000004299 sodium benzoate Substances 0.000 description 1
• 229960003885 sodium benzoate Drugs 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
• 229940080237 sodium caseinate Drugs 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
• LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
• 235000019250 sodium sorbate Nutrition 0.000 description 1
• 239000008247 solid mixture Substances 0.000 description 1
• 239000004334 sorbic acid Substances 0.000 description 1
• 235000010199 sorbic acid Nutrition 0.000 description 1
• 229940075582 sorbic acid Drugs 0.000 description 1
• 235000014347 soups Nutrition 0.000 description 1
• 235000013322 soy milk Nutrition 0.000 description 1
• 229940071440 soy protein isolate Drugs 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 235000013599 spices Nutrition 0.000 description 1
• 238000001694 spray drying Methods 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 229960004274 stearic acid Drugs 0.000 description 1
• 239000008174 sterile solution Substances 0.000 description 1
• 239000000021 stimulant Substances 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 239000006190 sub-lingual tablet Substances 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• TYFQFVWCELRYAO-UHFFFAOYSA-L suberate(2-) Chemical compound [O-]C(=O)CCCCCCC([O-])=O TYFQFVWCELRYAO-UHFFFAOYSA-L 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• 235000011044 succinic acid Nutrition 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid group Chemical group C(CCC(=O)O)(=O)O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• 229960004793 sucrose Drugs 0.000 description 1
• 150000005846 sugar alcohols Chemical class 0.000 description 1
• 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
• BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 description 1
• BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 230000005062 synaptic transmission Effects 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 238000001308 synthesis method Methods 0.000 description 1
• 238000010189 synthetic method Methods 0.000 description 1
• 229960001685 tacrine Drugs 0.000 description 1
• YLJREFDVOIBQDA-UHFFFAOYSA-N tacrine Chemical compound C1=CC=C2C(N)=C(CCCC3)C3=NC2=C1 YLJREFDVOIBQDA-UHFFFAOYSA-N 0.000 description 1
• 229940095064 tartrate Drugs 0.000 description 1
• 210000002435 tendon Anatomy 0.000 description 1
• KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
• 229930183689 terminalin Natural products 0.000 description 1
• 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
• 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 229960003604 testosterone Drugs 0.000 description 1
• 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
• 125000005888 tetrahydroindolyl group Chemical group 0.000 description 1
• 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
• 125000003831 tetrazolyl group Chemical group 0.000 description 1
• 125000001113 thiadiazolyl group Chemical group 0.000 description 1
• 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 1
• 239000003848 thrombocyte activating factor antagonist Substances 0.000 description 1
• 208000013818 thyroid gland medullary carcinoma Diseases 0.000 description 1
• 239000004408 titanium dioxide Substances 0.000 description 1
• 229930003799 tocopherol Natural products 0.000 description 1
• 239000011732 tocopherol Substances 0.000 description 1
• 235000010384 tocopherol Nutrition 0.000 description 1
• 229960001295 tocopherol Drugs 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
• 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
• 235000021404 traditional food Nutrition 0.000 description 1
• 230000037317 transdermal delivery Effects 0.000 description 1
• 125000005270 trialkylamine group Chemical group 0.000 description 1
• 125000001425 triazolyl group Chemical group 0.000 description 1
• IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
• 229940078499 tricalcium phosphate Drugs 0.000 description 1
• 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
• 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
• 125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 description 1
• PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 1
• 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 239000012588 trypsin Substances 0.000 description 1
• 229960004799 tryptophan Drugs 0.000 description 1
• 229960004747 ubidecarenone Drugs 0.000 description 1
• 229940035936 ubiquinone Drugs 0.000 description 1
• 238000002604 ultrasonography Methods 0.000 description 1
• 238000000825 ultraviolet detection Methods 0.000 description 1
• DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 229960002726 vincamine Drugs 0.000 description 1
• 229960000744 vinpocetine Drugs 0.000 description 1
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 235000019156 vitamin B Nutrition 0.000 description 1
• 239000011720 vitamin B Substances 0.000 description 1
• 239000008170 walnut oil Substances 0.000 description 1
• 230000003313 weakening effect Effects 0.000 description 1
• 208000027121 wild type ATTR amyloidosis Diseases 0.000 description 1
• 239000002023 wood Substances 0.000 description 1
• 210000002268 wool Anatomy 0.000 description 1
• 239000008096 xylene Substances 0.000 description 1
• 229940071104 xylenesulfonate Drugs 0.000 description 1
• 235000008924 yoghurt drink Nutrition 0.000 description 1
• 235000013618 yogurt Nutrition 0.000 description 1
• 150000003751 zinc Chemical class 0.000 description 1
• 235000016804 zinc Nutrition 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011787 zinc oxide Substances 0.000 description 1
• 235000014692 zinc oxide Nutrition 0.000 description 1
• 239000011590 β-tocopherol Substances 0.000 description 1
• 235000007680 β-tocopherol Nutrition 0.000 description 1
• 239000002478 γ-tocopherol Substances 0.000 description 1
• 239000002446 δ-tocopherol Substances 0.000 description 1